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8:00am Registration
Session One – Setting the Scene
Chairperson: Professor Gerry Boyle, Director, Teagasc.
9:00am Opening of Conference
 Professor Gerry Boyle, Director, Teagasc.
9:10am Antimicrobial Resistance (AMR) the way forward.
 Martin Blake, Chief Veterinary Officer,
 Department of Agriculture Food and the Marine (DAFM).
9:30am Why reducing antibiotic use is now an imperative.
 Professor Martin Cormican, NUI Galway.
10:05 am Antibiotic usage data – its value for the animal health sector.
 Caroline Garvan, DAFM.
10:25am The environment and its role in the transmission and persistence of AMR.
 Dearbhaile Morris, NUI Galway; Fiona Walsh, NUI Maynooth;
 Kaye Burgess and Fiona Brennan, Teagasc.
10:45am Tea/ Coffee
Session Two – Meeting Consumer Demands
Chairperson: Dr Lisa O’Connor, Food Safety Authority of Ireland.
11:15am Dairy farm system management without antibiotics –
 lessons from Scandinavia.
 Martin Kavanagh, Veterinary Consultant, Tipperary.
11:45am Addressing antimicrobial usage in agriculture:
 considering citizen perspectives and consumer demands.
 Áine Regan and Sharon Sweeney, Teagasc; Claire McKernan, Tony Benson 
 and Moira Dean, Queen’s University Belfast.
Session Three – Panel Discussion
Chairperson: Tommy Heffernan, Irish Farmers Journal.
12:05pm Farmer experiences at reducing antimicrobial use (AMU) on their farms.
 Panel
 Eamonn Sheehan, Dairy Farmer.
 Brian Doran, Beef Farmer.
 Ger Carey, Drystock Unit Manager, Gurteen Agricultural College.
 Roy Gallie, Pig Farmer.
12:45pm Lunch
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Session Four – Break-Out Concurrent Sessions
13:45pm Six Parallel Sessions, arranged to facilitate discussion and interaction.
 Each presentation is repeated after 1 hour
 Attendees are requested to choose 2 sessions
Please attend the workshop you are booked into
15:45 pm Tea/ Coffee
Session Five – Take Home Messages and Actions
Chairperson: Professor Michael Diskin, Teagasc.
16:15pm Take home messages and actions for veterinary profession
 and each enterprise
 David Graham, CEO, AHI.
16:45pm Closing remarks
 Michael Creed, TD, Minister for Agriculture, Food and the Marine.
17:00pm Conference Close
No Title Speakers Convenor Room
1 Selective Dry Finola McCoy George Ramsbottom P&H Egan 1&2
 Cow Therapy (AHI) (Teagasc)
2 Responsible Prescribing David Tisdall Eoin Ryan DE Williams III
 of Antimicrobials (University of Surrey) (UCD)
3 Calf Emer Kennedy Tom O’Dwyer DE Williams II
 Management (Teagasc) & (Teagasc)
 and Health Catherine
  McAloon (UCD
4 Biosecurity, Carla Gomes Michael McKeon Goodbody 1&2 
 Medicated Feed (AHI) & (Teagasc)
 Pigs & Poultry Rob Doyle (DAFM)
5 Anthelmintic Resistance Orla Keane James O’Shaughnessy DE Williams I
 (Cattle and Sheep)  (Teagasc)  (DAFM)
6 Lameness in Sheep Joe Angell Michael Gottstein Goodbody 3&4
  (Veterinary (Teagasc)
  Consultant, UK)
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Foreword 
Given the serious global public health threat of antimicrobial resistance 
(AMR) I welcome the holding of this One Health conference focusing 
on AMR, and anthelmintic resistance. The Department of Agriculture, 
Food and Marine continues to focus on a joined-up approach to animal 
health under the One Health umbrella. 'One Health' is an approach to 
designing and implementing programmes, policies, legislation and 
research in which multiple sectors communicate and work together to 
achieve better public health outcomes. The challenge of AMR underpins 
the One Health concept.
Ireland’s National Action Plan on Antimicrobial Resistance (iNAP), 
jointly developed with colleagues from the Department of Health, and 
the environment sector, recognises the urgent and growing problem 
of antimicrobial resistance for human health worldwide. It is currently 
being implemented through successful stakeholder leadership and collaboration. 
Anthelmintic resistance has been widely reported in parasites of a number of livestock species in Ireland, 
and is now an increasing problem nationally. Globally, resistance to all currently used antiparasitic veterinary 
medicinal products has been demonstrated. Resistance to anthelmintics is developing year-on-year, and is 
now a significant animal health issue.  There is a responsibility on the agri-food industry to address its part 
in the major global challenge posed by AMR and anthelmintic resistance.
This conference aims to both inform veterinary practitioners and farmers from the various animal sectors, 
and to also allow for discussion and debate around key interventions that can be put into practice to combat 
AMR and anthelmintic resistance. This conference places an emphasis on not simply increasing awareness, 
but also highlighting actions that can be taken to mitigate against the risk of further development and 
spread of both AMR and anthelmintic resistance.
Tackling AMR and anthelmintic resistance collectively is critically important to achieving sustainable 
development of the agri-food sector. I wish to thank my colleagues in Teagasc, my department, Animal 
Health Ireland, University College Dublin and the Food Safety Authority of Ireland for organising this event. 
I hope you find this conference informative and that you leave with a better understanding of your respective 
roles and responsibilities to keep antibiotics and anthelmintics working effectively into the future.
Michael Creed, TD.
Minister for Agriculture, Food  and the Marine 
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Opening Address
Antimicrobial Resistance (AMR) is a serious threat to public health 
around the world with potential consequences for everyone, so I am 
particularly pleased that this One Health conference is taking place now. 
We have a responsibility to play our part to preserve the effectiveness of 
antibiotics for future generations. The Agri-food sector, both in Ireland 
and internationally, has a significant role to play to safeguard the use of 
antibiotics for society. 
Our first step should be to reduce antibiotic usage in animal production 
systems. Achieving high standards of animal health, will not only benefit 
primary producers from a productivity perspective, but will reduce our 
use of antibiotics to treat sick and ill animals, thus reducing the risk of 
developing antimicrobial resistance. 
The overuse of antimicrobials, whether in human or veterinary medicine, is a key driver in the emergence of 
antimicrobial resistance. AMR could reverse the benefits achieved in animal health care and in human health 
care over the last 100 years. We could potentially see standard treatments for bacterial diseases becoming 
The message from the One Health conference is clear: the more antibiotics we use, the more resistant bacteria 
that will emerge. Reducing antibiotics use in the animal health sector is critical to addressing AMR.
So what does this mean in practical terms, on the ground, on farms? On dairy and suckler farms, it means 
moving away from “blanket dry cow therapy” to “selective dry cow strategies” in order to reduce antibiotic 
use. There are some positive indicators that this is happening. Ireland has seen a 33% reduction in the use 
of in-lactation intramammary treatments in the last decade, and a 25% reduction in the use of dry cow 
intramammary antibiotics in the last five years.
When rearing calves it means feeding 3 litres of colostrum within 2 hours of birth to allow the calf develop its 
own immunity. This needs to be coupled with good hygiene practices, the provision of adequate calf nutrition 
and suitable calf housing and a focus on areas to reduce stress. All of the above can contribute to reducing 
disease on farms and thereby reducing the need for antibiotics. On sheep farms, the practical steps include 
the use of non-antibiotic strategies to prevent lameness in flocks and the avoidance of blanket treatment 
with antibiotics and their non-use in footbaths. The implementation of a rigorous herd bio-security plans, 
and or, planned vaccination programme are also important elements in promoting herd health and reducing 
the dependence on antimicrobials and anthelmintics and very consistent with the adage “that prevention 
is better than cure”. This One Health conference is also addressing the issue of Anthelmintic Resistance in 
ruminants in Ireland. Worm infections in the gut of grazing lambs and calves, has a negative impact on the 
animals performance. Resistance to benzimidazole (1-BZ: white wormer), levamisole (2-LV: yellow wormer) 
and macrocyclic lactone (3-ML: clear wormers) has now been identified on Irish cattle and sheep farms. I 
would urge farmers to adopt worm control strategies that delay the further development of Anthelmintic 
Resistance.
I would like to thank my colleagues in Teagasc, who along with colleagues in the Department of Agriculture, 
Food and the Marine, Animal Health Ireland, University College Dublin and the Food Safety Authority 
of Ireland, for organising this One Health conference. They have brought together the expertise and the 
knowledge to help the Irish agri-food industry to address this issue. We are highly dependent on exporting 
our food outputs and being able to demonstrate a low level of antibiotic usage in food producing animals will 
become more important in the future.
Professor Gerry Boyle,
Teagasc Director
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Antimicrobial resistance (AMR) -
the way forward
Martin Blake
Chief Veterinary Officer, 
Department of Agriculture Food and the Marine, Agriculture House, Kildare Street, Dublin 2.
Introduction
The World Health Organisation (WHO) has defined Antimicrobial Resistance (AMR) as “a catastrophe 
that must be managed with the utmost urgency”. AMR is estimated to be responsible for 33,000 
deaths per year in the EU alone and 700,000 deaths per year globally, including 230,000 deaths 
from multidrug-resistant tuberculosis. It has been calculated that the extra healthcare costs and 
productivity losses due to multidrug-resistant bacteria in the EU total €1.5 billion each year. The 
discovery of antibiotics in the last 100 years has revolutionised health care and prolonged global 
life expectancy by an estimated 20 years. Without effective antimicrobial cover routine surgical 
procedures and cancer chemotherapy become high risk and infections that were once deemed 
relatively minor have the potential to kill. In animal health, antibiotics are vital ‘tools’ to protect 
animal health and welfare in both companion and food producing animals. AMR is a natural 
phenomenon and represents a process of natural selection. Every time we use antibiotics we select 
for resistant bacteria. The misuse and overuse of antibiotics accelerates the rate at which resistance 
develops. Reducing the use of antibiotics in both the human and animal health sectors is seen as a 
key intervention in tackling AMR.
The use of antibiotics in the farming sector is coming under increasing scrutiny in light of the very 
real public health threat of AMR. Whilst the relative contribution of resistance development within 
animal production systems is not quantified and is subject to debate, it is now unquestioned that 
actions need to be taken within the agriculture sector to reduce the rate of resistance development 
overall. Antibiotics are a precious resource which needs to be safeguarded for the benefit of both 
humans and animals.
Take home messages
•	 AMR is a serious global public health threat with potentially devastating consequences for all 
of us and our families.
•	 Antibiotics are a precious resource and we all have a responsibility to preserve their effectiveness 
for future generations.
•	 Agri-food production systems have a responsibility to society – to citizens and consumers at 
home and abroad - to safeguard the use of antibiotics.
•	 Our primary goal must be to reduce antibiotic usage through achieving the highest possible 
standards in animal health.
•	 As a country highly dependent on our agri-food exports, Ireland needs to demonstrate a low 
level of antibiotic usage in food producing animals in line with the claims currently being made 
by our competitors.
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Ireland’s Response to Reduce Antimicrobial Usage (AMU) and AMR
In response to the challenge of AMR, Ireland has adopted a One Health approach – which recognises 
that human, animal and environmental health are all interconnected. A One Health approach is 
recognised by the World Health Organisation and the European Commission as key to tackling 
AMR. In association with the Department of Health, the Department of Agriculture, Food and the 
Marine (DAFM) jointly established the National Interdepartmental AMR Consultative Committee 
in 2015 which brought together key industry stakeholders from the human health, animal health 
and environmental sectors. This committee has supported the development and launch of Ireland’s 
first three year national action plan to address AMR - Ireland’s National Action Plan on Antimicrobial 
Resistance 2017-2020, also referred to as iNAP. The plan recognises the urgent and growing problem 
of antimicrobial resistance for human health worldwide. It aims to implement policies and actions 
to prevent, monitor and combat AMR across the health, agricultural and environmental sectors. 
This plan recognises that no one sector can successfully address AMR alone. 
The aim of iNAP is to keep antibiotics working as effective disease treatment tools in both human 
and animal health. The plan identifies 5 strategic objectives - focussed on (i) improved awareness 
and knowledge, (ii) enhanced surveillance on antimicrobial usage and antimicrobial resistance, (iii) 
reducing the spread of infection and disease, (iv) optimising the use of antibiotics in humans and 
animals, and (v) promoting research and sustainable investment in new medicine, diagnostic tools, 
vaccines and other interventions. Fifty two (52) actions have been identified to be delivered within 
the animal health and environmental sectors. It is pleasing to note the sustained collaboration and 
leadership shown by industry stakeholders in undertaking these projects. 
One significant output has been the publication in January 2019 of the first One Health Report 
on Antimicrobial Use and Antimicrobial Resistance which brings together usage and resistance 
surveillance data in both the human and animal health sectors. This first cross sector report is 
an important milestone in contributing to effective evidence based policy making with regard to 
meeting the challenge of AMR spread. Of particular interest in the animal and environmental 
sectors was a nationwide survey of Irish farmers conducted by the Irish Farmers Association (IFA) 
and the Animal and Plant Health Association (APHA) which has identified a high level of awareness 
amongst farmers of AMR and its potential impact. Eighty five percent of farmers revealed that they 
are concerned about AMR and 92% of farmers identify an immediate need for greater awareness of 
AMR amongst all involved in agriculture. 
A further key project under iNAP is the development of a national database to record antimicrobial 
use in animals, as at present we only capture data for antibiotics sold in Ireland and we cannot easily 
identify the sectors and sub-sectors in which the antibiotics are being used. DAFM is leading on this 
project which will ensure that progress in reducing the overall level of antibiotic consumption can 
be demonstrated. Measuring antimicrobial use is a key component in the overall effort to reduce 
use. Quantifying antimicrobial usage also allows the impact of the new initiatives which target 
a reduction in usage to be measured. Measurement can also drive behaviour change by virtue of 
engaging in the activity, i.e. being involved in the system is in itself a motivation to change behaviour. 
Prevention is better than cure
Building on one of the key enabling principles of the National Farmed Animal Health Strategy 
2017-2022 - “prevention is better than cure”, a number of initiatives at improving animal health are 
underway. Historically, the primary role of the veterinary practitioner has been on treating animals 
that have poor health or are diseased, where the economic output from the animal is already reduced 
due to ill health. The principle of ‘prevention is better than cure’ seeks to change the focus from one 
of post event response management/treatment of disease to one that promotes animal health as 
a driver of optimised production, improved margins for producers and providing the best quality 
food for consumers. Healthy animals do not need antibiotics. The farmed animal private veterinary 
practice network is a significant repository of knowledge and expertise that can guide herd health 
planning and preventive veterinary medicine. 
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Veterinary medicine usage, in particular the use of antibiotics, needs to be part of an overall 
farm animal health plan focussed on the prevention of disease in the first instance through good 
husbandry and management practices. Furthermore, when using antibiotics it is important to 
limit their use to only what is necessary. Measures to foster closer links between veterinarians and 
farmers emphasise the professional health care advisory role of the veterinarian, and enables them 
be familiar with the animals and conditions to be treated in a targeted manner. This engagement 
facilitates longer term planning, including investments in preventive measures. Other providers of 
farm advisory services – for example those that relate to nutrition, breeding, production systems 
and indeed service providers for such as foot care and milking machine maintenance must also 
keep in mind that their interventions and advice can impact on animal health and welfare and thus 
influence the development of AMR. An increased focus on preventive measures and subsequent 
improvements in animal health reduces the need for treatments with antimicrobials. 
The challenge with intensive production systems 
Intensive production systems present particular challenges in terms of disease control and currently 
account for over 60% of the total quantity of antibiotics used in Ireland on an annual basis. The 
“Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal 
husbandry in the European Union, and the resulting impacts on food safety” (RONAFA report) 
identified that oral administration of antimicrobials in livestock is of particular concern in terms 
of promoting the development of AMR due to the high exposure of gastrointestinal commensal 
bacteria, and the sometimes prolonged duration of treatment or exposure, especially for products 
administered in feed. In many Member States, there has recently been a notable shift away from 
the use of medicated feed to the use of drinking water for the oral administration of antimicrobials 
in a more targeted way to animals in need of treatment. It is widely accepted that sick animals 
will stop eating before they stop drinking so the effectiveness of using medicated feed to deliver 
antimicrobials to clinically affected animals is being challenged. 
Critically Important Antibiotics (CIAs)
As well as reducing the overall amounts of antimicrobials used it is important to consider the types 
of antimicrobial, and the way they are used. In several countries there are regulations restricting 
the use of certain classes of antimicrobials, or particular antimicrobial use practices. The types of 
antimicrobials which are subject to these restrictions are identified as ‘Highest Priority Critically 
Important Antimicrobials’ (HP-CIAs), as they are considered to be critically important for human 
health, being used as last line therapies for treatment of critically ill patients in our hospitals 
when the first line antibiotics have failed to work. Given the importance of HP-CIAs in human 
health, strict controls should be applied to their use in veterinary medicine. In November 2018 
DAFM, in consultation with the iNAP Animal Health Implementation Committee, published a 
policy document which endorsed the recommendations of the WHO and the European Medicines 
Agency’s Antimicrobial Advice ad hoc Expert Group (AMEG). This policy document recognised 
fluoroquinolones, 3rd and 4th generation cephalosporins, colistin and macrolides as HP-CIAs and 
provided guidance as to their use in veterinary medicine. We need to ensure that these antimicrobials 
remain effective for people and animals into the future. Veterinary practitioners should only 
prescribe these antimicrobials when no other treatment will work, as proven by the results of 
culture and sensitivity testing of samples taken from clinically affected animals performed by an 
accredited laboratory.
Changing landscape of antibiotic use in veterinary medicine in the EU
New regulations on veterinary medicines will come into effect in January 2022. These aim to reduce 
antimicrobial usage in food animals and include a reinforced ban on the use of antibiotics as growth 
promoters, as well as the following provisions and principles:
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1. Antibiotics must not be applied routinely,
2.  Antibiotics must not be used to compensate for poor hygiene, inadequate animal husbandry, or 
poor farm management, 
3. Antibiotics must not be used for prophylaxis (preventive treatment to a healthy animal) except 
in very exceptional circumstances,
4. Antibiotics must not be used for metaphylaxis, (treatment of healthy cohort animals) except 
when the risk of spread of an infection or of an infectious disease in the group of animals is high 
and no other appropriate alternatives are available; 
5. Restrictions apply regarding the use of certain types of antibiotics (e.g. HP-CIAs);
6.  Veterinary prescriptions should be based on clinical examination or other proper assessment, 
are only valid for 5 days; and are limited to the amount required for the treatment concerned. 
The focus of the new regulations is to protect human health first and foremost and addressing the 
challenge of AMR has been the key driver for the new content in these regulations. Mistakenly in the 
past, one perspective on prevention being better than cure resulted in the increased prophylactic use 
of antibiotics and sometimes in an imprudent manner. The new regulations will require a change in 
the way we use antibiotics and practices such as in blanket dry cow therapy and the prophylactic use 
of in-feed antibiotics to alleviate the threat of disease in intensive production systems will no longer 
be an accepted ‘norm’. It is clear that veterinary practitioners, who have been assigned a privileged 
role as prescribers and indeed gatekeepers of antibiotics in the animal health sector, have a key role 
in promoting the responsible use of antibiotics in the sector.
Antibiotics and the Consumer
Ireland is a major exporter of food with agri-food comprising 10% of national exports and valued 
at approx €13.6 billion annually. Consumers and corporate customers value the confidence they 
have in the safety and wholesomeness of food and ingredients produced in Ireland – built on 
transparency, traceability, surveillance, contingency responses, animal health programmes and 
controls. Our industries have ambitious targets for growing these exports even further. Combined 
with increasing demand from more affluent and discerning customers in key world markets, we 
need to meet consumer expectations under several headings, not least of which is food safety. 
International trade in food and feed is expected to rise significantly in order to nourish the global 
population. Consumers are taking much more of an interest in how their food reaches their table. 
People are becoming more aware of antimicrobial resistance as a threat to their health and this is 
leading to a growth in consumer demand for more ‘antibiotic free’ produce. This is a worrying trend, 
which although it might seem a good idea from a marketing perspective, could have unintended 
consequences. Such a ‘directive’, which promotes a prohibition on the use of antibiotics without 
reference to context, raises concerns in relation to possible delays in the control of animal disease 
or in the protection of animal welfare – we must always remember that animals are sentient beings!. 
Our goal should not be to produce food that can be labelled as antibiotic free but rather to produce 
food from healthy animals in a way that minimises the need for antibiotic usage. It is essential for 
Irish producers to step up and provide leadership so we can demonstrate to all, be that stakeholders/
consumers in this country or in our markets abroad, that we take the threat of AMR seriously and 
that we are committed to taking the action to ensure the levels of antibiotic used in food production 
in Ireland are at a very low level 
Reducing the need for antibiotics in food animals
While many of the strategies employed to reduce antimicrobial use in other countries have focused 
on modifying behaviour with regard to use, efforts to reduce the need for antimicrobials can have 
a huge impact on the development and spread of AMR. Husbandry and management practices on 
farms can significantly impact on the health of animals – thus change in farm practices and/or 
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infrastructure is often the necessary first step in the prevention of animal disease. Vaccination is 
the cornerstone of any herd health plan to boost herd immunity and reduce the incidence of clinical 
disease as well as reducing the shedding of pathogens by infected animals. Progress has been made 
over recent years in the area of disease prevention, with increased use of vaccines to protect against 
certain animal disease threats. 
Ireland has been successful in recent years with the eradication of certain diseases from the national 
herd – e.g. Bovine Brucellosis, Aujeszky’s disease. There are also various industry-led initiatives 
aimed at addressing specific disease challenges. Animal Health Ireland, (AHI) a public-private 
partnership, jointly funded by government and industry, has promoted and developed a number of 
disease eradication and control programmes including BVD eradication, Johne’s Disease control and 
Cellcheck – these are playing a very significant role in improving the health status of the national 
herd with the knock on effect of reduced AMU which contributes to the ongoing battle against 
AMR. DAFM is also currently supporting two industry groups with initiatives within the intensive 
pig & poultry sectors - a Pig Industry Stakeholder Group and the Poultry Industry Campylobacter 
Stakeholder Group.
Biosecurity 
Biosecurity is a core element of ‘prevention’ – serving to minimise risks and thus protecting the 
health of farmed animals. Farm boundary biosecurity practices in Ireland are not particularly 
robust. Developing a national approach to on-farm biosecurity is one of DAFM’s key priorities for 
2019 and will form a key component of a holistic approach by DAFM to ensure the sustainable 
development of Ireland’s agri-sector. Currently, funding is made available to all commercial pig 
farmers, through the Targeted Advisory Service for Animal Health (TASAH) mechanism under 
the co-funded Rural Development Programme to have a comprehensive and objective ‘Biocheck.
UGent’ biosecurity review carried out on their farms by a trained private veterinary practitioner. I 
am pleased to announce that this initiative has just now been extended to the poultry sector. 
Anthelmintic resistance 
Just as bacteria have evolved to develop mechanisms to avoid being killed by antibiotics, parasites 
such as gastrointestinal nematodes have also developed resistance to the anthelmintics that have 
been widely used over the past 50 years to control them. While anthelmintic resistance has been 
recognised globally as a major challenge in intensive sheep production systems for some time, more 
recent evidence has emerged of widespread resistance to certain anthelmintics in cattle. It is now 
clear that the old advice to “dose and move in July” - which was in fact highly selective for anthelmintic 
resistance, is no longer valid and measures to delay the development of resistance must be adopted 
on farm. This requires more comprehensive targeted approach to identifying the need for and the 
most appropriate dosing strategy at farm level – both to ensure immediate effectiveness for the 
individual farmer but also from a broader industry perspective, to reduce risk of further resistance 
development. The widespread development of resistant parasites in sheep and cattle, both internal 
and external, is a major threat to animal health, welfare, productivity and the sustainability of 
the cattle and sheep farming sectors worldwide. Greater attention to grazing practices, husbandry 
practices and nutrition to help reduce the need for anthelmintics, as well as a targeted, evidence-
based and selective approach to the use of anthelmintics, similar to that required for antibiotics, is 
warranted.
Conclusion
The challenge of AMR must be addressed and cannot be ignored. It is clear that attitudes and 
behaviours relating to antibiotic use are changing. Whilst acknowledging progress so far, it will 
require a sustained effort by all stakeholders to mitigate the risk posed. A good reference point is 
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to recall that healthy animals do not need treatment with antibiotics and that reduced antibiotic 
use is the primary strategy in reducing the development of AMR. Measures must be taken to keep 
animals free from disease through good animal husbandry and management practices. Prudent 
use of antibiotics, which may be summed up by the EP-RUMA tag line that we should aim to use 
antibiotics “as little as possible but as much as necessary” is similarly important. It will also be 
necessary to review the implications of in-feed medication in the context of prudent use objectives. 
A “Code of Good Practice Regarding the Responsible Prescribing and Use of Antibiotics in Farm 
Animals” was launched in November 2018 and is available for download at www.agriculture.gov.ie/
amr . 
The development of and spread of AMR is a challenge for public and animal health into the future. 
Veterinarians, as the prescribers of antimicrobials, and farmers have a key role to play in keeping 
antibiotics effective for future generations through improving animal health and reducing levels 
of antibiotic usage on farms. It is clear that a multi-faceted approach with buy in from all actors 
in the food supply chain is required to achieve long lasting behavioural change in the way we use 
antibiotics in order to tackle the complex issue of AMR. As the Irish proverb goes “Ní neart go 
cur le chéile”. A collaborative approach involving all stakeholders along the food chain including 
veterinary practitioners, farmers and farm advisors is key to reducing the levels of antimicrobials 
used on Irish farms in order to mitigate the risk of AMR development.
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Why reducing antibiotic use
is now an imperative
Martin Cormican
Consultant Microbiologist Galway University Hospitals,
Professor of Bacteriology NUI Galway School of Medicine ,
National Clinical Lead Antimicrobial Resistance & Infection Control Team Division of Microbiology,
Saolta University Health Care Group,
University Hospital Galway
Introduction – the problem
Antimicrobial resistance (AMR) means that antibiotics that we have depended on for decades no 
longer work as well as they did or no longer work at all. Antimicrobial resistant bacteria are often 
referred to as “superbugs”. Antimicrobial resistance means poorer outcomes for people who get 
infected with AMR bacteria and higher costs for healthcare system and society. AMR also means 
that antibiotics no longer work for animals as well as they did in the past so that AMR is bad for 
both human and animal health and welfare.
The scale of the problem
The former UN Secretary General, Ban Ki-moon said antimicrobial resistance poses “a fundamental, 
long-term threat to human health, sustainable food production and development. It is not that it 
may happen in the future. It is a very present reality.” AMR is on the HSE Corporate risk register 
with the maximum risk rating of 25 and is identified in the Sláintecare Implementation Strategy 
as a key element in developing clinical governance and patient safety policy (Sub-Action 1.47). In 
October 2017 the Minister for Health and the Minister for Agriculture jointly launched Irelands 
National Action Plan for AMR (iNAP)
AMR is an existential risk to human and animal health. The scale of the risk and the cost of managing 
it grows with every month that it is not adequately addressed. A major outbreak of an antimicrobial 
Take home messages
•	 AMR is bad for both human and animal health and welfare.
•	 The OECD reports projects that infection related to antimicrobial resistant bacteria could “cost 
the lives of around 2.4 million people in Europe, North America and Australia over the next 
30 years” 
•	 Three out of four deaths could be averted by spending just 2 USD per person a year on measures 
as simple as hand washing and more prudent prescription of antibiotics.” 
•	 The things that work best require consistent application of good practice in the control of 
infection and the use of antibiotics, such as hand hygiene, general hygiene and safe use of 
antibiotics.
•	 There are no quick fix technical solutions to AMR. 
•	 Implementing the things that have been shown to work requires a deep change in how we do 
things in hospitals, communities and farms. 
•	 The change will require long-term investment to address key deficits and provide the leadership 
to drive a culture change at all levels of our communities. 
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resistant bug in one HSE hospital was estimated to have cost more than €2 million in a single 
year. AMR ultimately becomes an irreversible problem. On November 7 2018, the OECD published 
a report “Stemming the Superbug Tide” with the subtitle “Just A Few Dollars More”. The OECD 
reports projects that infection related to antimicrobial resistant bacteria could “cost the lives of 
around 2.4 million people in Europe, North America and Australia over the next 30 years” and 
that “three out of four deaths could be averted by spending just 2 USD per person a year on 
measures as simple as hand washing and more prudent prescription of antibiotics.” 
What does AMR mean for people who are patients? 
Consider a man who needs a bone marrow transplant to survive his cancer. While preparing for the 
bone marrow transplant in hospital bacteria that are resistant to many or most available antibiotics 
to spread to his gut (colonisation). If those bacteria progress move into his blood stream when he is 
at the most vulnerable point during the bone marrow transplant, his chances of recovering from his 
cancer are much reduced. The cost of his treatment will also be higher and he will probably spend 
more time in hospital. 
Even if the bacteria stay in his gut and never cause infection people are often very disappointed that 
the healthcare system was not able to protect them from picking up antimicrobial resistant bacteria. 
Carrying an antibiotic resistant organism often means having to accept isolation and restrictions 
on movement when in hospital. Some people find this distressing. 
Managing the problem 
Managing the problem requires that we make better use of antibiotics and have more robust systems 
to prevent antibiotic resistant bacteria from spreading. The processes put in place to support better 
use of antibiotics in the healthcare system are referred to as “antimicrobial stewardship” (AMS). The 
processes put in place to prevent bacteria from spreading and to prevent them causing infection are 
referred to as “infection prevention and control”. The risk of AMR is much more effectively managed 
in healthcare systems with very robust systems for antimicrobial stewardship and infection 
prevention and control (for example Sweden). 
Antimicrobial Resistance and Healthcare Associated Infection 
Many people who pick up AMR bacteria in a healthcare system will carry the bacteria but suffer no 
illness. This is called colonisation. Some of these people may develop infection with the antimicrobial 
resistant bacteria later. This is the situation described in the story above of the man with cancer. 
When new AMR bacteria appear in a country they are often spread early on within the healthcare 
system unless the healthcare system has robust infection control systems in place. Healthcare 
systems with inadequate infection prevention and control are, therefore, a risk both to the patients 
in the healthcare system and a risk to wider public health because they can amplify the spread of 
new AMR bacteria. Clean safe care means infection prevention and control principles are built into 
the foundations of every aspect of healthcare delivery. 
When AMR bacteria become established in a healthcare system an increasing proportion of 
healthcare associated infections are caused by these bacteria. These infections can be exceptionally 
difficult to treat. Patients are more likely to die if their infection is caused by AMR bacteria. In 
the past 40 years, the healthcare system in Ireland has greatly improved its infection prevention 
control capacity. However, it has not improved fast enough to keep pace with a more vulnerable 
patient population and new emerging infection risks including AMR. Several AMR bacteria are now 
embedded (endemic) in our healthcare system. These include bacteria such as methicillin-resistant 
Staphylococcus aureus (MRSA), extended spectrum beta-lactamase producing Enterobacterales 
(ESBL) and vancomycin-resistant enterococcus (VRE). Many of these resistant bacteria were very 
rare in Ireland as recently as 20 years ago. As AMR bacteria become more common in hospitals the 
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risk that they are carried out into the community becomes greater. The AMR bacteria are carried into 
the community in and on people. AMR bacteria are also carried out from hospitals in hospital sewage, 
particularly if the sewage is not properly treated. As a new type of AMR bacteria gradually becomes 
more common in the human population in the community they are more likely to contaminate 
the environment (septic tanks and sewage) and to cross over into animals. The AMR bacteria can 
then multiply in animals resulting in further potential for environmental contamination with 
AMR bacteria and contamination of the food chain with AMR bacteria. This can become a cycle of 
AMR bacteria or the genes that make bacteria resistant to antibiotics circulating between humans, 
animals and the environment. When we give antibiotics to people or animals some of the antibiotic 
is shed in the urine and faeces. This means that the environment is contaminated with both AMR 
bacteria and antibiotics. Some antibiotics can persist for a long time in the environment. The more 
antibiotics are used in humans and animals and the more they contaminate the environment the 
greater the advantage AMR bacteria have over ordinary bacteria. A “one health” approach looking at 
people, animals and the environment together is therefore critical to tackling AMR. 
The rapidly changing challenge of AMR 
New AMR bacteria appear in the world on a regular basis. No hospital in the world is more than a 
day away from Irish airports so we have to accept that new resistant bacteria will be introduced to 
Ireland all the time. Antibiotic resistant bacteria can also be carried from country to country and 
farm to farm in animals. 
The latest major AMR challenge introduced to Ireland is a group of bacteria called CPE (Carbapenemase 
Producing Enterobacterales). This is one of the most serious AMR problems we have faced to date. 
Very few antibiotics work to treat infection caused by CPE. There are not many new antibiotics for 
CPE in the pipeline. The number of people carrying CPE or infected with CPE detected in Ireland was 
41 in 2013 and was 537 in 2018. We estimate that there are probably over 1,000 people in Ireland 
currently carrying CPE. It is most likely that some people carrying CPE have not been identified 
at present however the dramatic improvement in CPE screening in the past year and a half has 
probably reduced the number of people with undetected CPE. There is also a lot of concern about 
bacteria with a particular gene called mcr that makes bacteria resistant to colistin. This problem was 
identified originally in China. Bacteria with the mcr gene have been detected in Ireland but very 
rarely and so far do not appear to have spread significantly. This maybe partly because there is very 
limited use of colistin in Ireland in either humans or animals. So far we do not have a problem with 
CPE in animals in Ireland but the CPE are the kind of bacteria that can transfer to animals so we 
must accept that there is a risk that this could happen. 
Antimicrobial resistance is a ‘’wicked’’ problem
We know a lot about what works to improving infection prevention and control and antimicrobial 
stewardship. Almost all of the things that work best require consistent application of good practice 
in the control of infection and the use of antibiotics, such as hand hygiene, general hygiene and safe 
use of antibiotics.
There are no quick fix technical solutions to AMR. Implementing the things that have been shown 
to work requires a deep change in how we do things in hospitals, communities and farms. The 
change will require long-term investment to address key deficits and provide the leadership to drive 
a culture change at all levels of our communities. 
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Antibiotic usage data - its value for the 
animal health sector
Caroline Garvan
Superintending Veterinary Inspector, 
Department of Agriculture Food and the Marine, Backweston Campus, Celbridge, Co Kildare.
Introduction
The misuse and overuse of antimicrobials, whether in human or veterinary medicine, is recognised 
as a key driver in the emergence and dissemination of antimicrobial resistance. AMR threatens to 
undo many of the advances made in human and animal health care in the past 100 years, potentially 
rendering standard treatments for bacterial disease ineffective, and infections that were once 
deemed relatively straightforward to treat fatal. In light of the fact that the more antibiotics we 
use, the more resistant bacteria we will have to deal with, our goal must be to reduce the use of 
antimicrobials in both the human health and animal health sectors. 
The importance of having data to substantiate claims of low antibiotic usage in Irish farming systems 
has never been more timely in order to galvanise consumer confidence against a backdrop of growing 
concerns around the global societal public health risk of AMR. Data is also an important to ensure 
Irish agri-food exports continue to be recognised as a high quality product in key world markets. The 
establishment of a national antimicrobial usage (AMU) database will play a vital part in defending 
access to current markets, as well as supporting negotiations to gain access to new markets. The 
AMU database will also contribute to our ongoing efforts to enhance Ireland’s reputation for high 
standards of animal health. As Ireland’s farm animal production capacity far exceeds its domestic 
demand, it is critical that access to increasingly competitive international markets is maintained 
and expanded to support the development of the agri-industry and the national economy.
Monitoring of antimicrobial use in other countries
Measuring antimicrobial use is a key component in the overall effort to reduce use. Quantifying 
antimicrobial usage also allows the impact of the reduction strategies being implemented to be 
measured. Until recently, only a limited number of countries monitored antimicrobial use stratified 
by species. Denmark and the Netherlands were the most notable of these. In recent years, many 
other countries have followed suit, for example Germany, Belgium, Spain, Italy, Switzerland and the 
UK. The systems employed in each country vary in terms of organisation, the species included and 
coverage of the population. Some are state run schemes such as Vetstat in Denmark and Presvet 
in Spain, the electronic national database for veterinary prescriptions. Voluntary initiatives driven 
by stakeholders can also be very effective to decrease AMU, for example the electronic medicines 
Take home messages
•	 Reducing the quantity of antibiotics being used in the both the human and animal health 
sector is paramount to addressing the challenge of AMR.
•	 Monitoring antibiotic use is a vital component of the overall effort to reduce usage “if you can’t 
measure it you can’t improve it”
•	 The collection of antibiotic usage data will be a vital tool to ensure consumer confidence and 
support international trade.
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book for pigs (eMB-pig) operated by the AHDB Pork in the UK and the antibiotic stewardship 
scheme operated by the British Poultry Council (BPC). In Denmark the close surveillance of the 
use of antimicrobials at the farm level through Vetstat has been – and still is – an important tool to 
provide a detailed understanding of antimicrobial usage, which has formed the basis for a number 
of interventions by stakeholders and allowed the impact of these interventions to be tracked..In 
Denmark and the Netherlands, there is virtually complete coverage of all the major species, while 
in other countries the data collection system may only cover a proportion of a given sector, or may 
be based on the sampling of a small number of farms. There are also differences in how the data is 
collected: prescription data is collected by a central database in Denmark, Spain, Italy, Switzerland 
and the Netherlands; farmers input their own data into the eMB-pig in the UK; while antimicrobial 
usage information is gathered at the level of the processors who compile information received from 
their growers in the case of the BPC. The AACTING consortium (Network on quantification of 
veterinary Antimicrobial usage at herd level and Analysis, CommunicaTion and benchmarkING to 
improve responsible usage) is a collaboration amongst many of these data collection systems and 
lists 28 such systems in 15 countries.
ESVAC Project
The ESVAC (European Surveillance of Veterinary Antimicrobial Consumption) project was 
established by the European Medicines Agency (EMA) in 2009 following a request from the European 
Commission to develop a harmonised approach for the collection and reporting of data on the use 
of antimicrobial agents in animals from EU and European Economic Area (EEA) member states. The 
EMA publishes an annual ESVAC report on the sales of veterinary antimicrobials and the most recent 
report published in October 2019 was based on 2017 data submitted by 31 countries. The report 
shows that overall; for the 25 countries reporting sales data to the ESVAC for each year from 2011 
to 2017, sales of antimicrobials fell by over 32% between 2011 and 2017. The sales of polymyxins 
plummeted by 66%, the sales of third  and fourth generation cephalosporins decreased by more 
than 20% and sales of fluoroquinolones declined by 10.3 %.Tentative explanations provided by the 
countries for the decline in sales across 2010 to 2017 include, among others, the implementation 
of responsible-use campaigns, the setting of targets, restriction of use, benchmarking, increased 
awareness of the threat of AMR, changes in animal demographics and changes in systems for 
collecting data. A large difference in the sales, expressed as mg/PCU, was observed between the 
most- and least-selling countries (range 3.1 mg/PCU to 423.1 mg/PCU across the 31 countries) 
for 2017. This is partially due to differences in the composition of the animal population in the 
various countries (e.g. more pigs than cattle). Furthermore, differences in the production system 
may play an important role. Among other factors, there is also considerable variation in terms of 
daily dosage and length of treatment between the various antimicrobial agents and formulations 
used. Aggregated across the 30 countries, the sales (mg/PCU) of pharmaceutical forms for group 
treatment accounted for 89.4 % of the total sales. Based on the 2017 ESVAC Report Total sales of 
veterinary antimicrobial agents for food-producing species (mg/PCU*) in Ireland have fluctuated 
marginally from year to year. Between 2016 and 2017, a decrease from 52.1 mg/PCU to 46.6 mg/
PCU was recorded, compared to a high of 55.9 mg/PCU in 2013. A slight increase of 2.3 % in tonnes 
of active ingredients sold was observed between 2015 and 2016.
*Population Correction Unit (PCU) is a measurement developed by the European Medicines 
Agency (EMA) and takes into account the animal population as well as the estimated weight of 
each particular animal at the time of treatment with antimicrobials.
This places Ireland below the overall total used in many other Member States. That said, it is 
important to note that a measure such as the mg/kg of overall live weight is a crude measure in 
that it mixes species that are likely to have relatively low usage with species where the usage is 
likely to be much higher. It does not take account of the type of antibiotic being used, with some 
formulations having much lower weights of active ingredients than others.
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Fig 1. Sales for food-producing species, in mg/PCU, of the various veterinary antimicrobial classes 
for 31 European countries in 2017. 
Ireland ranked 19th highest out of 31 EU/EEA MS for AMU in animals (mg/kg biomass) in 2017 
(see Figure 1).(European Medicines Agency, European Surveillance of Veterinary Antimicrobial 
Consumption, 2019.‘Sales of veterinary antimicrobial agents in 30 European countries in 2017’.
Fig 2. Oral solutions, oral powders and premixes as percentages of total sales,
in mg per population correction unit (mg/PCU), of veterinary antimicrobial agents
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Antimicrobial Usage Levels in Food Animals in Ireland
Data in relation to veterinary antibiotic consumption is collected at the national level by the 
Health Products Regulatory Authority (HPRA), as part of the European Surveillance of Veterinary 
Antimicrobial Consumption (ESVAC) project run by the European Medicines Agency (EMA). This 
data is published annually by the HPRA and at intervals by the EMA. The HPRA figures indicate 
that somewhere between 88 and 100 tonnes of veterinary antibiotics are sold annually in Ireland 
(Table 1).The total tonnage of veterinary antibiotics sold in Ireland in 2017 as reported by the 
Health Products Regulatory Authority (HPRA) was consistent with other years at 99.7 tonnes.. 
Many factors can play a role in these yearly fluctuations in the quantity of antimicrobials sold, such 
as seasonal disease prevalence, changes in the size of the national herd or product held in the supply 
chain between years. While the older classes of antibiotics such as tetracyclines, penicillins and 
sulphonamides made up the greatest proportion of total antibiotic classes sold, a worrying trend 
of increasing sales of antibiotics regarded as critically important for human medicine (HP-CIAs) 3rd 
and 4th generation cephalosporins and macrolides was observed. See Table 2. 
Table 1 Sales (tonnes sold) of veterinary antibiotics for the years 2013 – 2017 (source: HPRA)
 2013 2014 2015 2016 2017
Tonnes sold 99.1 89.4 96.9 103.4 99.7
Fig 3. Sales (tonnes sold) of different veterinary antibiotic classes for the years 2013 – 2017.
As in other years tetracyclines accounted for the greatest proportion of sales at 41.6% An increasing 
trend has been observed in the sale of 3rd and 4th generation cephalosporins and macrolides. 
Table 2. Sales (tonnes sold) of 3rd & 4th generation cephalosporins, flouroquinolones,
macrolides and lincosamides for years 2013- 2017.
 2013 2014 2015 2016 2017
3rd & 4th generation cephalosporins 0.17 0.24 0.22 0.25 0.30
Flouroquinolones 0.89 0.69 0.79 0.94 0.85
Macrolides and lincosamides 6.7 6.7 5.9 7.2 7.5
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Table 2 above shows an increasing trend in the sale of 3rd and 4th generation cephalosporins and 
macrolides which are recognised by DAFM as Highest Priority Critically Important Antimicrobials 
for use in human medicine as per World Health Organisation guidelines. The DAFM policy document 
on use of Highest Priority Critically Important Antimicrobials is available on the department’s 
website to download at: https://www.agriculture.gov.ie/media/migration/animalhealthwelfare/
amr/amrnovember2018/1DAFMHPCIAPolicy310119.pdf
Fig 4. Pharmaceutical form breakdown of veterinary antibiotics in 2017 in Ireland 
The 2018 HPRA report shows that the largest proportion of antibiotics sold are in the form of 
premixes and oral remedies at 66%.
AMU database
Ireland’s national action plan to tackle AMR, iNAP, launched in 2017, was jointly developed by 
the Department of Health and Department of Agriculture (DAFM) following consultation with key 
industry stakeholders. The aim of iNAP is to keep antibiotics working as effective disease treatment 
tools in both human and animal health. One of the projects under iNAP is the development of a 
national database on antimicrobial use in animals, as at present we only have data for antibiotics 
sold in Ireland and we cannot easily identify the sectors in which the antibiotics are being used. 
DAFM is currently working on constructing an antimicrobial usage database to capture real time 
information on current antimicrobial usage levels in food producing animals in Ireland. This 
database will provide granular data to quantify the volume of each different class of antimicrobial 
being used in Ireland and the species i.e. pig and subspecies level i.e. weaner/fattener/sow, that they 
are being prescribed to. With respect to food-producing animals in Ireland, there is a legal obligation 
that all medicines administered are recorded on-farm. Hhowever, there is neither central return nor 
collation of such data. Some indicative information can be obtained by examining antimicrobial sales 
data. The primary source of antimicrobial sales data is contained in figures collated and published 
by the HPRA for the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) 
programme. These assessments are based purely on data supplied voluntarily by manufacturers, 
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distributors and wholesalers, so are not point-of-use data indicating the species to which they were 
actually administered. The antimicrobial usage (AMU) database will assist in meeting a strategic 
objective of enhancing surveillance on antibiotic resistance and antibiotic use, as well as ensuring 
that progress in reducing the overall level of antibiotic consumption can be demonstrated. 
The database will be introduced progressively in a step-wise fashion, initially   capturing usage 
information from the intensive pig and poultry sectors and will eventually be extended to capture 
data from all food producing (cattle/sheep/horses) and companion animals (dogs and cats). As well 
as meeting a strategic objective under iNAP, this project reflects the requirements of the recently 
published EU Veterinary Medicine Regulations (EU) 2019/6 which requires all member states, within 
two years from 28th January 2022, to be collecting data from pigs and poultry, and by 28th January 
2027, be collecting data from all food-producing animal species. It is currently envisaged that 
initially the usage data from all species except pigs, will be gathered from prescribing veterinarians, 
with the plan to allow for real time recording of all medicines being used in food producing animals. 
Our primary objective is in relation to antimicrobial use, but we are also interested in getting 
information in relation to other veterinary medicine products over time, to include anthelmintics 
and vaccines. Information on antibiotic usage collected will serve to inform reduction strategies on 
a national level. These reduction strategies will focus on actions to improve animal health.
Ireland’s new national AMU-pig database is being launched in November 2019 by the Department 
of Agriculture, Food and the Marine (DAFM) This database will gather data on farm level antibiotic 
usage in Irish pigs with farmers submitting antibiotic usage information on a quarterly basis. All pig 
herd owners who slaughter more than 200 pigs per year will be required to submit their antibiotic 
usage information to DAFM. It will be a requirement under Bord Bia’s Farm Quality Assurance 
standard for pigs that all eligible farmers submit their antibiotic usage data to DAFM.
Benchmarking 
Benchmarking schemes provide a platform for veterinarians and farmers to compare the quantities 
of antimicrobials prescribed and used with others in the same farming sectors. Benchmarking 
also allows identification and monitoring of those prescribers and end users which deviate 
significantly from the average. If appropriate, specific interventions may be required to address 
factors contributing to these outliers where excessive prescribing or use is identified. Similarly 
benchmarking allows identification of examples of best practice where there is minimal on farm 
usage and these practices can be communicated and shared with the sector as a whole. One of the 
best known of these initiatives is the so called ‘Yellow Card’ scheme in Denmark which applies to 
cattle and pig farms, and was established in 2010. Thresholds are set for each production category, 
and if they are breached, the farmer receives an official warning and will be subject to increased 
supervision, with in some cases, restrictions on access to antimicrobials. On farm interventions 
are also suggested by veterinary consultants in order to reduce disease levels on farm. The collection 
of antibiotic usage data in Ireland will allow farmers to compare their AMU to that of their peers 
which will act as a catalyst for change.
Conclusion
Ireland is in the enviable position that it can produce significantly more animal based products 
than it can utilise internally for its own citizens, thus it is a very large exporter of agri-products. 
Whilst this is a very significant national resource, its value is dependent on achieving access to 
growing markets across the world, to realise its maximum value to Irish producers and the economy 
as a whole. Improving Ireland’s animal health status, and being able to demonstrate a low level of 
antibiotic use in animals is a primary element in trade negotiations with third country markets, 
as is the credibility of its farmed animal health systems and food safety and control systems. 
Performance measurement and animal health surveillance data from the farmed animal sector are 
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often needed to facilitate trade negotiations, so it is only a matter of time before there will be a 
request to provide data on antibiotic use. It is of vital importance that we monitor antibiotic usage 
in animals nationally in order to provide, interpret and disseminate data that facilitate risk analysis, 
disease modelling and decision making, meeting the needs of the farmed animal sector as well as 
meeting the overall aim of reducing antibiotic usage thereby mitigating the risk of AMR. As the 
saying goes “if you can’t measure it you can’t improve it “and nowhere is this more relevant than 
monitoring AMU.
References
ESVAC- “Sales of Veterinary Antimicrobial Agents in 31 Countries in 2017”. Available at: https://
www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-31-european-
countries-2017_en.pdf
HPRA Report on consumption of veterinary antibiotics in Ireland during 2017. Available at: http://
www.hpra.ie/docs/default-source/default-document-library/draft-report-on-consumption-of-
veterinary-antibiotics-in-ireland-during-2017.pdf?sfvrsn=0
24 | ONE HEALTH: Awareness to Action Antimicrobial and Anthelmintic Resistance Conference
The environment and its role in the 
transmission and persistence of 
antimicrobial resistance
Dearbháile Morris1, Fiona Walsh2, Fiona Brennan3
and Catherine M. Burgess4*
1 National University of Ireland Galway
2 Maynooth University, Co. Kildare
3 Teagasc Environmental Research Centre, Johnstown Castle, Wexford
4 Teagasc Food Research Centre Ashtown, Dublin
* All authors have contributed equally
Introduction
Antimmicrobials such as antibiotics are naturally produced by microorganisms as a protection 
mechanism from competing microflora. The soil microbiome has been a source of antimicrbobials 
since their discovery and use as medicines. This fight for survival also occurs in water. Bacteria have 
developed strategies to evade or overcome the low levels of antimicrobials naturally produced by 
their community for millennia. Bacteria may be intrinsically resistant to antimicrobial agents or 
may acquire resistance as a consequence of genetic change. Antimicrobial resistance genes (ARG) 
are frequently located on mobile genetic elements, e.g. plasmids, allowing for rapid transfer of 
resistance determinants between bacteria of different species and within different environmental 
niches. It is only when these protection mechanisms are selected for and transfer to pathogens of 
animals, humans and plants that they become a threat. It is thought, and certain examples have 
been demonstrated to show, that these resistance mechanisms used by environmental bacteria 
to protect themselves from antimicrobials have moved into pathogens e.g. blaCTX-M-15. During the 
survival of the fittest those with an advantage live and those without die. When antimicrobials 
are added to the soil or water environments the bacteria with the antimicrobial resistance survive 
and grow as their non-antimicrobial resistant competitors are killed. This enables the numbers 
of antimicrobial resistant bacteria to proliferate. The increased numbers, therefore, increase the 
chance of the resistance mechanisms spreading and reaching human, animal or plant pathogens. 
One route for this is via the food chain. Potential routes for the dissemination of antimicrobials, 
antimicrobial resistant organisms (AROs) and ARGs are illustrated in Figure 1. 
In order to minimise and stop these transfers we need to understand what antimicrobial resistance 
is present in the environment, how it happens, whether it can move and what happens when we 
alter the environment or add antimicrobials to it. The waste of today could select the antimicrobial 
resistant bacteria of tomorrow.  
Take home messages
•	 The environment is a source and reservoir of antimicrobial resistance
•	 Antimicrobial resistance in the environment can transfer into the food and feed chain
•	 Farm management practises can influence antimicrobial use and antimicrobial resistance 
transfer into the environment
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Fig 1: Antimicrobial, antimicrobial resistant organisms and antimicrobial resistance determinant 
transmission routes in the environment. Image prepared by Daniel Ekhlas, Teagasc.
Antimicrobial usage in humans and its link to the environment 
There are a number of different types of antimicrobial resistant organisms (ARO), some of which 
are resistant to the last resort antibiotics, e.g. the carbapenemase producing Enterobacteriaceae 
(CPE). In many cases of infection with CPE there are very few available options for treatment, e.g. 
colisitin, tigecycline and fosfomycin. Unfortunately, reports of resistance to last resort agents are 
emerging, including the recently reported findings of plasmid-encoded colisitin resistance (mcr-1) 
initially in pigs in China, and subsequently in humans and animals worldwide (Canieux et al, 2017). 
The mcr-1 story dramatically illustrates the links between humans, animals and the environment in 
the context of antimicrobial resistance (AMR) and make it imperative that a “One-Health” approach 
is adopted to tackle the problem of AMR. 
The emergence and dissemination of AMR is related to use of antimicrobial agents.  Antimicrobial 
agents have been used for decades in humans and animals and for other applications. Wise (2002) 
has estimated the total annual world-wide antimicrobial market consumption to lie between 
100, 000 and 200,000 tons. Klein  et al.,  (2018) recently reported that antibiotic consumption in 
76 countries increased 65% between 2000 and 2015.   It is only recently that attention has been 
given to the impact that discharge of ARO, ARG and of antimicrobials (after administration) from 
humans and animals has on the environment and the pivotal role that the environment plays as 
that link between AMR in animals and humans which makes a “One Health” approach  imperative. 
Globally the major sources of antimicrobials, ARO and ARG in the environment include human and 
animal waste, inappropriate disposal of unused antimicrobial agents, and effluent from facilities 
manufacturing antimicrobial agents. On any given day, about one in every three patients in a major 
hospital in Ireland is taking antibiotics. In many cases, a patient may be on several different antibiotics 
simultaneously. The situation is similar in long term care facilities (, 2017). Most recent European 
Surveillance of Antimicrobial Consumption Network (ESAC-Net) data reveals that Ireland is ranked 
9th of 25 EU member states for antibacterial consumption in humans, consuming 26.1 defined 
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daily doses (DDD) per 1000 inhabitants per day, with 90% of this consumption occurring in the 
community sector (Department of Health/Department of Agriculture, 2019).  A significant quantity 
of the antimicrobial agents given to patients in healthcare institutions is shed into the wastewater 
stream in urine or faeces, in a form that is still biologically active. Furthermore, and related in part 
to the use of antimicrobial agents in healthcare institutions, a high proportion of patients have 
ARO resident in their gut, significant numbers of which ultimately enter the urban wastewater 
stream. In Ireland, similar to many countries across Europe, hospital effluent is generally released 
untreated into the urban wastewater stream for treatment at an urban wastewater treatment plant 
(WWTP) prior to discharge into the environment. A recent study of hospital effluent and the urban 
wastewater stream before and after the hospital effluent discharge point reported that CPE is more 
commonly detected in both hospital effluent and post-hospital wastewater than in pre-hospital 
wastewater (Cahill et al, 2019)   However, it is recognised that dealing with hospital effluent in 
isolation will not substantially address the overall issue of ARO in urban wastewater and that there 
are high levels of antimicrobial resistant E. coli in general urban wastewater.
It is recognised that wastewater is an important transmission route for ARO to the environment. 
In general, wastewater is treated prior to discharge to receiving waters.   Morris et al. (2016) 
demonstrated that although effective wastewater treatment greatly reduced the number of ARO, 
some do survive and are discharged to seawater9 thereby contaminating the natural environment.
Antimicrobial usage in animals and its link to the environment
In primary production antimicrobials play a critical role in disease prevention, limiting the impact 
of disease outbreaks and ensuring animal health and welfare. Therefore they have an important 
role to play in livestock production, when used appropriately and prudently. However, in recent 
years there has been an increasing focus on the misuse and overuse of antimicrobials in food 
animal production and the role it has to play in the increases observed in antimicrobial resistance 
globally. The recent One Health Report on Antimicrobial Use and Antimicrobial Resistance (Department 
of Health/Department of Agriculture, 2019) outlines that although the relative contribution of 
resistance development within animal production systems is not quantified and subject to ongoing 
debate, there is no doubt that ARO are transferred between animals and humans and that action is 
needed. It logically follows from this that antimicrobial usage in animal production systems can also 
have an impact on AMR levels in the environment.
Antimicrobial usage in veterinary medicine can impact on the levels of antimicrobial resistance in 
the environment in a number of ways.   Their usage can drive the selection and dissemination of 
AMR in the animals which can then transfer to humans via the food chain through consumption of 
contaminated produce or through contact with the animals. The ARO can also be disseminated into 
the environment through faeces. In addition, many antimicrobials can be excreted un-metabolised/ 
partially metabolised in animal faeces/urine. This can occur in the field or in houses, where 
waste products are stored, often for later application onto the land as slurry or manure. If these 
products contain antimicrobial residues it may provide a selective pressure for the development of 
antimicrobial resistance in the environment.
Aside from the use of antimicrobials there are other selective pressures for the development of 
AMR which may exist in animal production settings and the natural environment. Linkages have 
been shown between certain biocides and AMR and also that heavy metal resistance genes can be 
co-located with AMR genes, indicating that the presence of heavy metals, such as zinc or copper, 
may also impact on AMR dissemination. A number of research projects are now ongoing in Teagasc 
examining these linkages and the impacts these may have on AMR levels in the natural environment. 
One such project is co-funded through the One Health European Joint Programme which brings 
together 39 food, veterinary and medical laboratories from across Europe to undertake projects, 
education and training in the areas of foodborne zoonoses, antimicrobial resistance and emerging 
threats.
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Addressing antimicrobial use in veterinary medicine
To help address the issue of antimicrobial use in veterinary medicine and its link with AMR the 
World Health Organisation has developed and applied criteria to rank antimicrobials according 
to their relative importance in human medicine which is now on its sixth revision (World Health 
Organization, 2019). This document is intended for public health and animal health authorities, 
practicing physicians and veterinarians, and other interested stakeholders involved in managing 
antimicrobial resistance to ensure that all antimicrobials, especially critically important 
antimicrobials, are used prudently both in human and veterinary medicine. Similarly, the World 
Organization for Animal Health (OIE) has a list of antimicrobial agents of veterinary importance. 
Information on antimicrobial usage in veterinary medicine in Ireland is currently based on sales data. 
The most recent data available for 2016 indicates that tetracyclines, sulphonamides, trimethoprims 
and penicilins account for over 80% of sales and that the critically important antimicrobials such as 
third and fourth generation cephalosporins and fluoroquinolones are used at low levels (Department 
of Health/Department of Agriculture, 2019). One of the challenges with the use of sales data is 
that it does not provide a breakdown by species, age or the number of animals treated. In order to 
have a better understanding of antimicrobial usage and the drivers in different species a number 
of DAFM and Teagasc funded ongoing research projects will provide a much greater understanding 
of antimicrobial usage and resultant antimicrobial resistance development. Ongoing studies on 
the impact of manure spreading (EPA/HSE funded project AREST) and the impact of manure 
treatment options (JPI-AMR/HRB funded project INART) on AMR dissemination will also facilitate 
a much greater understanding of the contribution of antimicrobial usage in livestock production to 
antimicrobial resistance in the environment.
Antimicrobial resistance in the farm environment
Antimicrobial resistance and antimicrobial residues can be introduced into the farm environment 
through a number of pathways. Of particular concern is the introduction through faecal material and 
urine from animals treated with antimicrobials, especially where large amounts of antimicrobials 
have been administered. Manures can act reservoirs for AMR and a wide range of antimicrobial 
residues that can be dispersed into the environment. This includes into soils, waters (both surface 
and groundwaters) and crops where they can potentially come into contact with humans through 
direct contact or through contamination of the food chain. The landspreading of manures, slurries 
and farmyard manures is widely used within agricultural systems as an essential mechanism of 
recycling valuable nutrients and organic matter to soils - a valuable practice both in terms of 
maintaining soil health and crop nutrition, and a means of reducing inorganic fertiliser application 
requirements. Antimicrobial resistance and antimicrobial residues can be directly deposited by 
grazing livestock on to pastures or grazed rotational crops. Further, transmission can also occur 
from the built environment (where animals are housed) to the natural environment from runoff 
or washings from buildings or yards in contact with animal faecal material.  Once introduced into 
the natural environment, AMR and antimicrobial residues from manure can act as a reservoir for 
further contamination throughout the farm to fork pathway. How AMR or residues persist will 
be transmitted in the environment is poorly understood but it is known to be dependent on a 
range of factors including the nature of the antimicrobial and a range of soil, environmental and 
climatic factors such as soil texture, pH, temperature, soil organic matter and moisture content. In 
general bacteria containing AMR genes and the genes themselves will reduce in numbers over time 
following manure application so soils can facilitate a reduction risk if the antimicrobial is retained. 
However, in some cases soils may act as sources of AMR risk.
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Fig 2: Landspreading of bovine manure.
In addition to the potential transfer of AMR through the environment into the food chain, the 
release of antimicrobials, and the addition of AMR to the farm environment, can impact what 
microorganisms are present in soils, plants and waters, and what they can do by inducing a selective 
pressure within microbial communities in the environment. These organisms, within the natural 
environment, carry out important functions that underpin crop growth and health, that mediate 
soil structure, and that regulate climate and major nutrient cycles.  These functions can be impacted 
by antibiotics and other antimicrobials. For example, a recent international study has shown that 
manure from cows treated with antibiotics reduced carbon sequestration, thus increasing production 
of greenhouse gases responsible for climate change (Wepking 2019). Other studies have found the 
abundance and diversity of the soil microbial community is altered with antibiotic addition to soils 
and that this can also impact the capacity of the microbial community to use carbon and to produce 
enzymes (Cycon 2019). Resistance genes also have the potential to move from manure into members 
of the native microbial community through horizontal gene transfer. Often the consequences of the 
release of AMR or antimicrobial residues on the function of microbial communities in the natural 
environment are difficult to predict. Preliminary evidence suggests that mitigation options such 
as anaerobic or aerobic digestion, manure storage or composting can be effective at reducing risk 
of landspreading manures (Cycon 2019). Ensuring manure is spread in suitable soil conditions, 
reducing erosion and compaction risk, and excluding livestock from watercourses are all measures 
that may be effective in reducing transmission of AMR in the environment.
Antimicrobial resistance in waterways 
The aquatic environment represents an important potential route for transmission of antimicrobial 
resistance (organisms and genes) to humans, animals and the food chain. Surface waters are often 
discharge points for wastewater or runoff from agricultural land, whilst also serving as sources 
of drinking water supplies and/or waters used for food production and recreational purposes. 
Cormican et al., (2012) highlighted the extent of contamination of Ireland’s aquatic environment 
with AROs. This study found that between 6 and 80% of E. coli in contaminated drinking water 
supplies were resistant to ampicillin. This study also reported detection of extended spectrum beta-
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lactamase (ESBL)-producing E. coli in effluent from a WWTP, and vancomycin resistant enterococci 
in the source of a rural group water supply
Throughout Europe, a number of studies have reported the presence of carbapenemase-producing 
Enterobacterales (CPE) in recreational waters (Zurfluh et al, 2013).   Mahon et al. (2017) reported 
the first detection of CPE in seawater in Europe. The same two strains of CPE (NDM-19-producing 
Escherichia coli and Klebsiella pneumoniae) were detected in seawater, fresh water and sewage samples, 
indicating the discharge of untreated human sewage was the probable source of CPE. Ongoing 
monitoring of seawaters at these locations confirmed persistent contamination of seawaters with 
CPE over a 16-month period. This study also confirmed consistent contamination of seawater 
and freshwater with ESBL-PE from multiple sources. Whole genome sequence analysis revealed 
a number of ESBL-PE strains identified in seawater samples were also identified in sewage and/or 
fresh water samples, indicating that these outflows act as dissemination routes for these strains to 
receiving bathing waters. A number of STs (e.g. ST10 and ST23) and genes (e.g. blaCTX-M-1) were only 
identified among isolates originating from water samples and not from sewage or clinical samples. 
ST10 and ST23 have previously been reported among ESBL-E. coli isolated from animals in Ireland 
and elsewhere. These findings suggest that these isolates could be of animal origin and warrants 
further investigation.  
Conclusions/recommendations
The high quality reputation of produce associated with the Irish agricultural sector is reliant on the 
production of safe food produced in an environmentally sustainable way.  Antimicrobial resistance 
is a major threat to human health and there is a clear necessity to assess risks associated with 
transmission to the food chain. It is clear that the environment has an important role to play in 
any potential transmission and thus a better understanding of how AMR is transmitted in the 
environment will enhance our capacity to develop and implement effective and practical mitigation 
options. There is an urgent need to bridge the knowledge gaps that exist in our understanding 
of the role of the environment in the persistence, evolution and transmission of antimicrobial 
resistance, and for formalised monitoring of AMR in the environment. Bridging these knowledge 
gaps can only be effectively achieved by adopting a one health approach through harmonization 
of environmental surveillance with human and animal surveillance systems for antimicrobial 
resistance. Better stewardship of antimicrobial use within agriculture and improved manure and 
livestock management practises will help reduce the transfer of AMR within the environment and 
reduce the risk of transmission from farms into the food chain. 
References
Cahill, N., O’Connor, L., Mahon, B., Varley, A., McGrath, E., Ryan, P., Cormican, M., Brehony, C., Jolley, 
K.A., Maiden, M.C., Brisse, S., Morris, D. 2019. Hospital effluent: a reservoir for carbapenemase-
producing Enterobacterales? Science of the Total Environment. 672: 618-624.
Cycon´ M, Mrozik A and Piotrowska-Seget Z 2019. Antibiotics in the Soil Environment—
Degradation and Their Impact on Microbial Activity and Diversity. Front. Microbiol. 10:338. doi: 
10.3389/fmicb.2019.00338 
Cormican, M., Cummins, E., Morris, D., Prendergast, M., O’Donovan, D., O’Flaherty, V. 2012. 
enhancing Human Health Through Improved Water Quality. Available from: http://www.epa.ie/
pubs/reports/research/health/EPA_Cormican_EHHWC_webFin%20%281%29.pdf 
Department of Health/Department of Agriculture, Food and the Marine (2019). Ireland’s first One 
Health Report on Antimicrobial Use and Antimicrobial Resistance. Available at https://health.gov.
ie/national-patient-safety-office/patient-safety-surveillance/antimicrobial-resistance-amr-2/
30 | ONE HEALTH: Awareness to Action Antimicrobial and Anthelmintic Resistance Conference
Health Protection Surveillance Centre (HPSC). 2017. Point Prevalence Survey of    Healthcare‐
Associated Infections & Antimicrobial Use in Long‐Term Care Facilities (HALT)- May 2013- 
Ireland. 1–94.
Klein, E. Y.   Van Boeckel, T.P., Martinez, E. M., Pant, S., Gandra, S. Levin, S.A., Goossens, H. 
Laxminarayan, R. 2018. Global increase and geographic convergence in antibiotic consumption 
between 2000 and 2015. PNAS, vol. 115, no. 15, E3463–E3470.
Mahon, B. M., Brehony, C., McGrath, E., Kileen, J., Cormican, M., Hickey, P., Keane, S. Hanahoe, 
B., Dolan, A. Morris, D. 2017. Indistinguishable NDM-producing Escherichia coli isolated from 
recreational waters, sewage, and a clinical specimen in Ireland, 2016 to 2017. Eurosurveillance 1–5 
(2017). doi:10.2807/1560-7917.ES.2017.22.15.30513
Morris, D., Harris, S., Morris, C., Cummins, E., Cormican, M. 2016. Hospital Effluent, Impact on 
the Microbial Environment and Risk to Human Health. Available from: http://www.epa.ie/pubs/
reports/research/water.
Wepking, C. , Badgley, B. , Barrett, J. E., Knowlton, K. F., Lucas, J. M., Minick, K. J., Ray, P. P., 
Shawver, S. E. and Strickland, M. S. 2019. Prolonged exposure to manure from livestock‐
administered antibiotics decreases ecosystem carbon‐use efficiency and alters nitrogen cycling. 
Ecol Lett. doi:10.1111/ele.13390
Wise, R. Antimicrobial resistance: priorities for action. 2002. J. Antimicrob. Chemother. 49, 585–586. 
World Health Organization (2019). Critically important antimicrobials for human medicine, 6th 
revision. Available online at https://www.who.int/foodsafety/publications/antimicrobials-sixth/
en/ 
Zurfluh, K., Hächler, H., Nüesch-Inderbinen, M. & Stephan, R. 2013. Characteristics of extended-
spectrum ß-lactamase- and carbapenemase-producing Enterobacteriaceae isolates from rivers 
and lakes in Switzerland. Appl. Environ. Microbiol. 79, 3021–3026.
ONE HEALTH: Awareness to Action Antimicrobial and Anthelmintic Resistance Conference | 31
Dairy farm system management without 
antibiotics – lessons learned from 
working in Scandinavia
Martin Kavanagh, 
Cow Solutions, Tipperary, Ireland. 
Introduction 
Since 2009, I have worked in Sweden as a Veterinary Consultant on high production dairy farm 
units, varying in size from 150 to 1000 milking cows, usually housed in ‘cold’ freestall barns. There 
are 340,000 dairy cows in Sweden, and 4000 dairy farms of which approximately 520 are classified 
as organic. A total of 375 herds have > 200 cows. Up to 50% of the cows live in ‘warm’ freestall 
barns, with 17% in ‘cold’ freestalls and the rest are in tie-stalls. Cows are high producing, with 
annual yields in Holstein/Friesian cows in excess of 10,000 litres per year. In Sweden, between 35 
and 40% of the cows are culled from the herd each year at an average age of 60.5 months (Växa 
Sverige Cattle statistics. 2017).
Regulations on the use of antibiotics & Sales of Antibiotics 
Regulations governing the use of antibiotics in cattle have been in place in Sweden since the 
removal of growth-promoting antibiotics in feed in 1986, and with limitations of the use of 
therapeutic antibiotics in farm animals since the mid-90’s. The WHO classifies 3rd and 4th generation 
cephalosporins, fluoroquinolones and polymyxins as “highest priority critically important 
antimicrobials i.e. HP-CIA”. 
In 2018, the sales of these three classes of antibiotics in Sweden were 0.002, 0.037 and 0.044 mg/ 
PCU, respectively. This represents decreases since 2009 by 92%, 82% and 66%, respectively. For 
the 3rd generation cephalosporins and fluoroquinolones, the decrease is partly explained by a 
regulation limiting veterinarians’ rights to prescribe these types of antimicrobials (SJVFS 2013:42) 
(Consumption of antibiotics and occurrence of antibiotic resistance in Sweden: SWEDRES SVARM 
Report 2018). The total sales (kgs of active ingredient) in all terrestrial species from 2009 to 2018 
is shown in Fig. 1
Take home messages 
•	 Regulations limiting the use of therapeutic antibiotics in farm animals have been in place in 
Sweden since the mid 90’s.
•	 Overall sales in Sweden of therapeutic antibiotics for animal use have fallen by 30% since 
2009.
•	 Prudent use of humane euthanasia of animals with a poor prognosis is viewed as a welfare 
management tool and can chime with the need to demonstrate low mortality at farm level.
•	 System-oriented approaches to farm performance management are critical to managing cow 
and calf health in order to reduce the dependency on therapeutic solutions.
•	 Veterinarians providing Herd Health advice need to understand farm performance and 
provide feasible and practical solutions that align with the farm goals.
•	 There is an urgent need to fill knowledge gaps on the impacts of farm system design and 
animal health in order to limit the need for antibiotic therapy in the future.
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Fig. 1 The total sales (kgs of active ingredient) in all terrestrial species from 2009 to 2018
The sales in Sweden (Kgs of active ingredient) of three classes of Highest Priority Critically Important 
Antibiotics are shown in Fig. 2
Fig 2. The sales in Sweden (Kgs of active ingredient) of three classes of Highest Priority 
Critically Important Antibiotics
Swedish Veterinarian Policy
In 1998 the Swedish Veterinary Association (SVA) decided to adopt a general policy for the use 
of antibiotics in animals. The policy stated that antibiotics should never be used routinely or for 
preventative purposes as regulated by Swedish law, including regulation SJVFS 2015:31 which 
clearly states that third/fourth generation cephalosporins and flouroquinolones could be used only 
when an investigation concerning antimicrobial resistance has shown that it is absolutely necessary, 
as these antibiotics should be reserved for use in humans. The SVA gives clear guidelines for the use 
of antibiotics in animals for food production based on the following three principles:
•	 Firstly, ensure that the animal or group of animals has a disease that really needs to be treated 
with antibiotics. 
•	 Secondly, prudent use principles should be adhered to when using antibiotics, and therefore 
routine use should be avoided. 
•	 Thirdly, narrow spectrum antibiotics should be the preferred drugs of choice, and administered 
at the correct dose and correct duration of treatment. 
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Also, the SVA requires that when high treatment rates, or unorthodox use of antibiotics are 
discovered, the underlying reasons and/or predisposing factors should be investigated and corrected 
by means of disease prevention measures whenever possible.Currently, legislation requires that, 
fordairy farmers to be able to start a medical treatment in their animals (conditional delegated 
medicine use),farms must sign a contract with a veterinarian with special training in veterinary 
herd health management (VHHM) for regular visits, for follow –up treatments, and to encourage 
preventive work in the herd.
At farm level, this effectively translates into the first choice antibiotic as administered to cattle by 
the attending vet is most often than not a Benzylpenicillin. There are different treatment decision 
trees for differing conditions, with options to use tetracyclines and potentiated sulphonamides.
All antibiotics are sold under prescription through a registered pharmacy. The veterinarian does 
not stock or supply antibiotics beyond what is needed for treatment of clinical cases. There is little 
routine use of lactating cow mastitis tubes, and the use of dry cow tubes is uncommon. Animal 
welfare aspects must be considered. In some instances the correct clinical decision may be to not 
treat the animal with antibiotics. The expected outcome, general level of infection and potential 
spread of resistance genes in the herd may make it more prudent to euthanize the animal. 
On the dairy farms where I work there is a clear policy on decision-making regarding euthanasia 
of sick animals. This creates a dilemma for the attending veterinarian and the farmer, and also 
how welfare is measured and monitored at farm level. Cow longevity is often presented as a good 
indicator of both welfare and sustainability of a system, but in the case of some of the Swedish 
farms, animal mortality, where the animal is euthanized or dies on farm, can be as high as 8%. This 
reflects the need in many cases to use euthanasia as a welfare management tool. Cows that are 
experiencing chronic pain and have little chance of recovering within an acceptable time must be 
managed to alleviate unnecessary suffering. Prolonged therapy rarely results in a good outcome for 
the long term welfare of the cow.
Herd Health Management Programmes
In Sweden, systematic veterinary herd health management (VHHM) programmes have been in 
operation for over 20 years, however, to the constant surprise of visiting veterinarians from other 
countries, these services are not routinely used. It was revealed in a recent study into Swedish 
farmers’ experiences with VHHM that there were four main obstacles to veterinary involvement:
•	 costs, 
•	 veterinary knowledge, skills, and organization, 
•	 farmer attitudes”, and 
•	 veterinarian-farmer relationships
These studies showed that trust in the relationship, and the farmers’ trust in the understanding 
by the veterinarian of the farming business, influenced whether there was adherence to veterinary 
advice or not. It was very important to the farmers that any advice given was feasible and practical 
and aligned with their own goals and priorities.
 
Advantages Swedish Infectious Disease management systems:
Swedish cattle farms have a number of distinct advantages over Irish farms. Sweden has eradicated 
many of the major diseases that impact long-term cattle health such as, Brucellosis, Tuberculosis, 
Paratuberculosis (Johnes), Bovine Viral Diarrhoea BVD, Infectious Bovine Rhinotracheitis IBR, 
and Bovine Leukosis BVL. Swedish cattle are considered free of leptospirosis (2016 SVA). There 
are active biosecurity programmes, with 57% farm participation in ‘Safe Farm’ directed towards 
preventing salmonellosis. Salmonellosis is treated as a notifiable disease and restrictions are placed 
on the farm in the event of a positive diagnosis. 
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The farms are largely closed with little cattle movement between farms or regions. Visitors to the 
farms respect biosecurity and are conscious of disinfection and cleaning protocols. The uptake of 
vaccination is relatively low with the exception of vaccine for ringworm which is traditional due to 
an active trade in cattle hides. Uptake of pneumonia and scour vaccines is low ~10%. Even so, many 
of the main animal health issues are similar to Ireland; calf health, clinical and sub-clinical mastitis 
in cows, lameness and fresh cow diseases such as milk fever and metritis. Therefore production 
disease is the principle reason why an animal has to be treated. In Sweden, herds are getting larger 
and experienced and competent labour is harder to obtain, diseases of intensification, in particular, 
calf disease, mastitis and lameness, are becoming more difficult to deal with at the herd level. 
Developing a systematic approach:
In my opinion whilst working as a consulting veterinarian on Swedish farms, there was a need to 
develop a systemised approach to animal management based on the assumption that antibiotic 
treatment was not an option for problem-solving. Therefore, any effort that was put into remodelling 
management systems would yield long term benefits in reduced cost of production, increased profit 
and better animal performance. The most important element within this approach was the clear 
alignment of farm goals and priorities with the need to maintain a high standard of animal care. In 
my presentation I explore a systematic approach to farms where the antibiotic usage is limited by 
regulation and policy, and where the role of the veterinary surgeon is evolving beyond a treatment 
of acute cases into the role of animal performance planner. In each case, the farm system and profit 
goals are overviewed, and the constraints to calf and cow health are identified in the system. A 
management plan for each of the system elements based on the growth and production cycles on 
the farm is created, and some simple numerical monitors are used to check progress.
This approach is sustainable in that the health of the animals is a cornerstone of the profit goal. 
The animals on the farm must be fit for purpose, the environment that the animals live and work 
in must be fit for purpose, the feed and water management must be fit for purpose and the people 
who work and manage the farm must have the skills, the time, and the workplace to carry out their 
role effectively every day. The Farm System is outlined in Fig 3. 
Fig 3. The Farm System in Scandinavia. 
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There are seven broad parameters that I use on Swedish farms as Performance Monitors and these 
are adapted to the farm system depending on the availability of data, the goals of the farm and the 
robustness of the four pillars or compass points as illustrated in Fig 3. The monitors are:
1. Production performance in terms of yield of quality product sold over time
2. Feed intake as expressed by dry matter intake, feed efficiency and feed cost per unit of 
production
3. Fertility performance over time
4. ‘Wastage’ or culling/death over time
5. Calf and young stock performance and inventory over time
6. Transition cow performance over time
7. Lameness
These monitors are used to identify the constraints within the farm cycles of production. For 
instance, the daily or 24 hour cycle of the cow is concerned with rumen health, foot health and udder 
health, so the cows can fulfil their time budget of milking, eating and resting. The management is 
focused on the functional cow, dry matter intake and the ability of the cow to work in the system. 
The one year cycle is concerned with a cow calving every 365 days and follows the cow through feed 
and group changes from calving to calving. The one year cycle is a representation of body condition 
loss and gain through the production cycle and encompasses the herd fertility outcome. 
The two year cycle follows calf to calving heifer. The success of the calf programme and the avoidance 
of ‘sick days’ ensures a low young stock inventory, less feed used in the young stock system, 
realisation of genetic potential, and ultimately more functional cows. It all starts in the calf house 
and calf health is prioritised as it determines the future productivity of the herd. This feeds into 
body condition management and ultimately the retention of high fertility animals that are sound 
on feet, udder and have high feed efficiency. Sickness or excessive treatment signals a constraint 
in the system and the four pillars are reviewed. Often, unfortunately, the failure is as a result of 
someone not doing their job rather than something causing a problem. 
Application to Irish dairies
The same principles apply in relation to Irish dairy farms; dairy cow systems are no different from 
one country to another in reality. The common goal is to reduce disease and poor performance 
within the limitations of the system. So, identifying the right cow, the right environment, right feed 
and water, and right people is critical to reducing disease and antimicrobial use. 
Currently, in Ireland, I have the opportunity to work with a number of farms that are investing 
in system management rather than problem fixing. This involves having clear goals; for instance, 
reducing emergency treatments by better observation techniques, and teaching farmers and staff 
to use more supportive therapy such as pain relief and fluids. Each pillar of the system is worked 
through and remodelled. 
Also, on these farms, there has been a significant response to complete remodelling of calf rearing 
systems to reduce sick days, have easier work routines and better growth rates in more than 85% of 
the calves, using practical, feasible, and cost-effective solutions.
Conclusion
Working in Sweden, the success factors for me have been in understanding the needs of both 
the farmer and the animal, and more importantly, being able to provide practical advice that the 
farmer trusts and implements. While the Swedish farm and vet are subject to regulation in terms of 
antibiotic use, it provides an opportunity to truly understand the interaction of the four elements 
of the farm system to ensure that antibiotics are relegated to a bit player in the management of 
animal health. 
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To achieve lower usage of emergency therapeutics, and reduce the use of antibiotics to prevent 
disease, there has to be a change in mind set of both animal health advisors as well as farmers. The 
standards that are accepted for environments, work routines and feed management in many cases 
are not good enough to ensure that treatment is less necessary. There is a need for evidence based 
clinical research into these areas and there is a further need for animal health professionals to 
engage with the goals of farm performance within the context of the four pillars much more than 
within the confines of disease alone. 
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Introduction
In recent years, the Irish public has become more interested in the welfare of farmed animals 
(Eurobarometer 2016). However, the extent to which farm animal welfare features in everyday 
purchasing and consumption decisions varies significantly across consumers. Some consumers 
choose to follow animal-free diets because they are opposed to animal production practices from 
a welfare perspective; however, lifestyle choices such as veganism, ethical consumerism and 
flexitarianism are not just shaped by animal welfare concerns, but increasingly are influenced by 
consumers’ beliefs regarding animal-based diets, human health and environmental impacts. In the 
absence of food scandals, most consumers have relatively strong confidence in the supply chain. 
Reassured by regulatory processes and quality assurance schemes, consumers trust that produce 
reaching supermarket shelves and restaurant menus guarantees acceptable levels of animal welfare 
are met. With respect to consumption and purchasing decisions, some consumers care little about 
animal production methods and instead favour attributes such as cost, taste or convenience. For 
others, welfare attributes feature strongly in their decision-making and they pay close attention to 
labels such as ‘grass-fed’, ‘organic’ or ‘free-range’. Many consumers favour such products because 
they believe that produce from animals that have been looked after and treated well will be healthier, 
safer and better quality. Farm animal welfare as a concept holds strong support amongst the public, 
but the picture is much more complex in considering how it impacts on consumers’ consumption 
and purchasing habits. 
Antimicrobial use in agriculture: consumer awareness and perceptions
Similarly with the use of antimicrobials in agriculture, public attitudes may be formed in different 
ways. On the one hand, the public may be concerned about how antimicrobials in agriculture are 
contributing to the societal problem of antimicrobial resistance and may wish to see a reduction 
in their use. The extent to which consumers are concerned by this issue, and the extent to which 
this concern may then impact on consumer behaviour, has not been extensively explored in an 
Irish setting. We do, however, know that consumers prefer food products which are ‘natural’ and 
associate products free from antibiotics as being of higher quality; for this reason, some consumers 
Take home messages
•	 Consumer awareness and knowledge about the role of antimicrobials in agriculture is low.
•	 Responsible labelling and public engagement is needed to communicate effectively with 
consumers around farm animal welfare and the role of antimicrobials.
•	 The SWAB project will address current evidence gaps and identify consumer knowledge and 
awareness about antimicrobial resistance and antimicrobial usage in agriculture.
38 | ONE HEALTH: Awareness to Action Antimicrobial and Anthelmintic Resistance Conference
are willing to pay a premium for such products (Lusk et al., 2006; Regan et al., 2018). Research shows 
that consumers widely disapprove of the use of antimicrobials in livestock production to promote 
animal growth and performance, viewing their use as unnatural and inappropriate (Lusk et al., 
2006). The majority of the research carried out with consumers has looked at attitudes specifically 
towards the use of antibiotics used to enhance the performance and growth of animals: a practice 
that bears little relevance in Ireland due to a ban on the use of antimicrobials for such purposes. 
Limited research has explored consumers’ awareness and attitudes on the use of antimicrobials for 
treatment and prevention of illness, and the role of agriculture in tackling AMR. Of those studies 
carried out, there is mixed evidence. Some studies suggest that consumers are concerned by the 
preventative use and overuse of antibiotics, but do accept their use to treat disease where it occurs 
(Clark et al., 2016). A Eurobarometer (2018) survey revealed that 75% of Irish consumers agreed 
that farm animals should be treated with antibiotics if it was considered the most appropriate 
treatment for that sickness. However, a separate study with Irish consumers has also revealed a 
substantial segment of consumers who associate meat from animals free from antibiotic treatment 
as being of high quality and are willing to pay more for meat produced with good animal welfare 
standards (Regan et al., 2018). Research with the German and Canadian public also found strong 
consumer demand for reduced use of antibiotics in livestock production, although the authors 
caution that these consumers may not be fully aware of the potential repercussions on animal 
welfare if antibiotics are removed too quickly or without proper supports in place (Goddard et al., 
2017). Consumers themselves have acknowledged that they lack enough knowledge to make an 
accurate judgement on antimicrobial use in agriculture (Cornejo et al., 2018). There are suggestions 
that public knowledge levels around antimicrobial resistance and usage in agriculture are low. For 
example, in the Eurobarometer survey, 58% of Irish consumers surveyed did not know there is a 
ban on the use of antibiotics to stimulate growth in farm animals. This corresponds to the public’s 
lack of knowledge and awareness more generally on issues of farm animal welfare (Clark et al., 
2016; Cornejo et al., 2018; Eurobarometer 2016).
These studies collectively point to the need to increase awareness amongst consumers around the 
use of antimicrobials in agriculture to ensure informed and evidence-based opinions and decision-
making. A growing number of EU citizens believe that there is currently not enough farm animal 
welfare information available and would like to have more information regarding welfare issues 
in their own countries (Eurobarometer 2016). Increasing urbanisation and the separation of food 
production from consumption has contributed to a widespread lack of knowledge of modern 
production methods. Research has shown that public understanding of farm animal welfare is based 
on information that they receive mainly through television, internet, newspapers and social media, 
rather than on knowledge gained directly from interacting with agricultural actors and settings 
(Clark et al., 2016). Rather than simply wanting more information, consumers want accurate and 
consistent messages as they feel a lot of the information they are currently exposed to on animal 
production is conflicting or confusing.
Responsible labelling 
Reducing the use of antimicrobials in agriculture without compromising animal welfare requires 
significant changes at the farm level in terms of animal husbandry and livestock management, 
which initially can bring significant cost and time investment for the agricultural sector (Goddard 
et al., 2017). The question has been posed whether consumers are willing to absorb some of 
this cost by paying higher prices for animal-based products which are marketed on the attribute 
of reduced antibiotic use. This strategy first depends on consumers seeing added value in such 
products. If consumers are unaware or confused about the role of antimicrobials in production, 
then demand for products marketed on this attribute is likely to be low. Furthermore, and perhaps 
more importantly, in any strategy undertaken, there needs to be an assurance that consumers 
understand that antibiotic use can be reduced but cannot be fully eliminated in agriculture in order 
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to maintain appropriate animal welfare standards. 
Sick animals in need of treatment will continue to 
require antimicrobials.
For consumers, information received from food 
packaging is one of the most important criteria when 
making purchasing decisions. Labels are an important 
platform for disseminating welfare information and 
lessening the gap between consumers and agriculture. 
However, they need careful consideration when it 
comes to antimicrobial usage as labels can be limited in 
their ability to communicate complex messages. In the 
United States, consumer demand has driven the use 
of front-of-package voluntary label claims such as “no 
antibiotics ever” (NAE) or “raised without antibiotics” 
(RWA), particularly prominent in the US poultry 
industry (Lusk et al., 2006; Ritter et al., 2019). For 
producers signing up to such programmes, it means 
that antibiotics are never used for growth, performance 
or disease prevention and any animals treated with antibiotics for illness cannot then be sold under 
an NAE or RWA label. A survey with US poultry producers signed up to an NAE programme revealed 
that their decision to do so was market-driven (Singer et al., 2019). Perhaps of most note from this 
study were the findings that over 80% of respondents felt that NAE production could slightly or 
significantly worsen animal health and welfare and a significant number of respondents agreed 
that there were times in which maintaining the NAE label took precedence over animal health or 
welfare due to perceived consumer demand. Commentators have spoken of the pressures facing 
these producers who have invested in an NAE system not to treat sick animals with antibiotics at 
the cost of losing the NAE label (Ritter et al., 2019). The findings from this study illustrate a striking 
disconnect between concurrent consumer demands for no antibiotics in animal production, and 
the maintenance of high farm animal welfare standards. It points to the need for greater clarity of 
communication with consumers on the role of antimicrobials in farming. 
Labels such as “no antibiotics ever” or “raised without antibiotics” have been characterized as 
‘negative labels’ or ‘absence labels’ as they market the fact that a particular attribute (in this case, 
antibiotics) is not present in the product (Ritter et al., 2019). However, such negative labels run 
the risk of fuelling consumer confusion. We already know that many consumers lack sufficient 
knowledge about the role of antimicrobials in animal production. Thus, when presented with 
labels indicating “no antibiotics” in food products, some consumers are liable to misinterpret their 
meaning – for example, rather than interpreting the label message as the elimination of antibiotics 
for preventative treatment of animals during rearing and production, they may take it to mean that 
the food products are free from unsafe antibiotic residue levels (Ritter et al., 2019). This, however, 
could obviously led to detrimental misperceptions about unlabelled products. Voluntary ‘absence 
labels’ which aim for product differentiation on the topic of antimicrobial use may ultimately result 
in consumer confusion around what products are actually safe, healthy and of good quality. Instead, 
an approach is needed which communicates the proactive and positive approaches being taken 
within agriculture to reduce antimicrobial use, and which also explains the role that responsible 
use of antibiotics will continue to have in supporting good farm animal welfare. This would help to 
address current misperceptions and information gaps, lead to informed and engaged consumers, 
and better align to the on-farm reality of needing to undertake lengthy and costly investments 
to move towards a reduced-antimicrobial system (Singer et al., 2019). This is also reflected in 
objectives of Ireland’s National Action Plan on Antimicrobial Resistance (iNAP) where a commitment 
has been indicated to engage retailers to promote ‘antibiotic responsible’ rather than ‘antibiotic 
free’ campaigns. 
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A proactive approach to consumer engagement
In response to the need for a more holistic program, a One Health Certified (OHC) animal 
production certification programme is in development in the US by a coalition of animal production 
companies, non-governmental organizations, and scientists (Ritter et al., 2019). If products meet 
the requirements of this programme, they can bear a universal logo which promotes animal 
well-being, responsible antibiotic usage, and environmental sustainability – from a consumer 
perspective, the use of such a logo could minimize consumer confusion associated with different 
voluntary label schemes and enhance consumer trust through transparent auditing procedures. 
In the UK, Red Tractor standards were introduced in 2018 with a specific focus on the responsible 
use of antimicrobials. There is potential value in integrating responsible antimicrobial use 
more explicitly into farm quality assurance schemes to support responsible communication to 
customers and consumers, whilst also rewarding food producers with a verifiable claim of minimal 
antimicrobial usage. However, such an approach requires a thorough understanding of consumer 
demand and knowledge and an active involvement of consumers so as to target their concerns 
and meet their expectations (More et al., 2017). Currently, in Ireland, there is a lack of empirical 
evidence demonstrating how Irish consumers would respond to communication efforts specifically 
related to antimicrobial usage – via labelling, quality assurance schemes or otherwise. There is 
also a lack of empirical evidence regarding Irish consumers’ current knowledge levels related to 
AMR and antimicrobial use in agriculture, although existing literature suggests that it is likely 
low (Eurobarometer 2018). In the event that baseline knowledge levels are low, labels and logos 
– although a sound means for disseminating information to consumers – on their own will not 
be enough to increase consumer understanding and awareness. A proactive approach is needed 
to communicate to consumers the commitments and actions which are required and undertaken 
by farmers to reduce the use of antimicrobial drugs including significant investments to improve 
animal husbandry and undertake disease prevention measures and continued responsible use of 
antimicrobials where needed. Such complex messages cannot be communicated solely through labels. 
Greater engagement with the public by a range of actors (including farmers, veterinary bodies, and 
scientists) is also required, meeting consumers on the channels and platforms they currently use to 
receive information on farm animal welfare, as well as creating new opportunities for engagement 
and public participation (Ritter et al., 2019). Understanding consumer perceptions, and how they 
are formed, is a required first step in developing 
future initiatives seeking to engage and communicate 
with consumers on the topic of antimicrobial use in 
agriculture. 
Ongoing research with consumers in 
Ireland
Limited research has been carried out with consumers 
in Ireland exploring their perceptions of antimicrobial 
use in agriculture. An interdisciplinary research project 
funded by the Department of Agriculture, Food and the 
Marine aims to address this research gap. Surveillance 
Welfare and Biosecurity of Farmed Animals (SWAB) is a 
two-year research project addressing major current 
and emerging animal health and welfare challenges in 
the Irish agricultural industry.
As one component of this multi-faceted project, 
work is underway with consumers to explore their 
perceptions of farm animal welfare broadly, and 
to specifically explore their knowledge, attitudes 
Fig 1. Visual illustration of the current 
‘hot topics’ in consumer behaviour and 
farm animal welfare, generated from a 
literature review undertaken within the 
SWAB project. 
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and deliberations on the use of antimicrobials in agriculture in Ireland. A mixed methodology 
approach frames this research with qualitative and quantitative research methods employed. Focus 
groups and a large cross-sectional survey are being carried out with consumers in the Republic 
of Ireland and Northern Ireland. Co-design workshops will also be undertaken with the aim of 
developing communication materials and recommendations to increase consumer understanding 
and awareness, address consumer concerns, and increase consumer engagement on the use of 
antimicrobials in agriculture. Preliminary results from the first stage of this research will be shared 
and discussed during the One Health - Awareness to Action - Antimicrobial and Anthelmintic Resistance 
Conference. Themes to be explored include consumer perceptions of farm animal welfare, awareness 
and knowledge of AMR and the role of antibiotics in farming, and the consumer’s take on reducing 
the use of antibiotics in agriculture. 
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CellCheck guidelines for a selective 
dry cow strategy
Finola McCoy
Animal Health Ireland, Carrick-on-Shannon, Co. Leitrim
Introduction
This paper looks at the global issue of antibiotic resistance, and how antibiotic use can influence 
its development. It presents the current Irish data regarding intra-mammary antibiotic use and 
how that has changed over the last decade. Finally, it looks at ways to reduce antibiotic use on Irish 
dairy farms at drying off, while still protecting the udder health of the herd, based on national and 
international research.
What is antibiotic resistance?
While antibiotic resistance, or AMR (antimicrobial resistance) as it is usually referred to, is a natural 
phenomenon and has been around as long as antimicrobials have been, it is fast becoming part of our 
everyday vocabulary. This is because the pace at which it has been developing in more recent years 
has increased, and it is now recognised as being a significant threat to human health. Antimicrobial 
resistance is resistance of a microorganism to a drug to which it was previously susceptible. When 
the microorganism is a bacterium, and the drug to which it is resistance is an antibiotic, this is 
known as antibiotic resistance.
The importance of antibiotics in human and animal health
Since the discovery of penicillin in 1928, antibiotics have revolutionised human and animal health 
and improved the quality of all of our lives. However, this is now changing, with AMR effectively 
‘weakening’ these invaluable medical treasures. By 2050, it is estimated that AMR-related deaths in 
humans will have increased more than 10-fold globally, with more people dying of AMR than from 
cancer (Fig. 1). Hence the sense of urgency about addressing this issue, and doing so at a global level.
Antimicrobial resistance is linked to antibiotic use – increased antibiotic use in both humans and 
animals is linked to an increase in AMR. In relation to mastitis-causing pathogens, there is evidence 
to show that different bacterial species develop resistance to different antibiotic groups at different 
rates. Currently, antibiotics are used by doctors to treat sick people, and in the agricultural sector 
to treat animals. In recent years, there has been increasing recognition of the linkage between AMR 
in people and antibiotic use in animals. For these reasons, there is increasing scrutiny of the use of 
antibiotics in the agricultural sector. 
Take home messages
•	 Increased antibiotic use in both humans and animals is linked to an increase in AMR.
•	 Ireland has seen a 33% reduction in the use of in-lactation intramammary treatments in the 
last decade, and a 25% reduction in the use of dry cow intramammary antibiotics in the last 
five years.
•	 While “blanket dry cow therapy” has traditionally been recommended as best practice, there 
is now a move globally towards “selective dry cow strategies” in order to reduce antibiotic use 
on farm.
•	 A selective dry cow strategy is not without risk and should only be embarked on following 
consultation with your veterinary practitioner.
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Fig. 1. Estimated AMR-related deaths by 2050, relative to other causes of death.
There is agreement on the importance of antibiotics to treat sick animals. However, it is no longer 
considered acceptable that antibiotics should be used to prevent disease, particularly when there 
are other proven strategies. The focus of the Cellcheck programme is on improving herd and udder 
health, thereby reducing clinical and subclinical disease and reducing the need for antimicrobials. 
This is evident from analysis of Irish sales data (More et al., 2017), which shows a 33% reduction in 
the number of intramammary in-lactation treatments used, between 2008 and 2015 (Fig 2).
Fig. 2. In-lactation intramammary antibiotic usage in Ireland (2003-2018), based on sales data
The role of antibiotic dry cow therapy
The practice of dry cow therapy is being questioned in many countries, by farmers, consumers 
and society in general. Antibiotic dry cow therapy undoubtedly has an important role to play in 
treating infections that persist at the end of lactation and maximising cure rates. However, it has 
also traditionally been used to prevent new infections occurring over the dry period. Considering 
our changing attitude and approach towards the use of antibiotics in a ‘preventative’ fashion, do we 
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also need to rethink how and why we use dry cow therapy? And in fact, how do we define dry cow 
“therapy”? 
The sales data analysis previously referred to also indicated that up to 2015, annual sales of dry 
cow intramammary antibiotics were sufficient to treat 100% of the national milking herd i.e. all 
quarters of all cows are being treated at the end of lactation (Fig 3). This is what is referred to as 
‘blanket dry cow therapy’, which until recently was recognised as best practice in mastitis control 
and has made a very positive contribution to udder health in many countries. However, as we learn 
more about AMR and what drives it, we need to review what are considered best practice, as well 
as the implications of modifying those ‘traditional’ recommendations. There is a growing body of 
international and Irish research showing that antibiotic use at drying off can be successfully reduced 
in many herds (McParland et al., 2019; Vanhoudt et al., 2018). Nonetheless, change is not without 
risk, and hygiene during drying off and dry cow management are two areas in particular that need 
to be of a very high standard in order to manage this risk.
Fig. 3. Dry cow intramammary antibiotic usage in Ireland (2003-2018), based on sales data
What are the risks and benefits of selective dry cow therapy?
An alternative to blanket dry cow therapy is ‘selective dry cow therapy’. This is when only selected cows 
i.e. those with infected quarters, are treated with antibiotic before drying off. Internal teat sealer 
is often then used in the remainder of the herd as one of the measures to prevent new infections. 
While this is considered a more prudent use of antibiotic and would reduce antibiotic use on many 
farms, it should be recognised that this practice is not without risk. So what are the risks and how 
can they be managed?
1. The first risk is of introducing bacteria when any intramammary tube is infused into a quarter. 
When internal teat seal is used on its own, there is no antibiotic present as “backup” and 
so the potential consequences are even greater. These ‘introduced’ bacteria can cause severe 
cases of mastitis, sometimes resulting in death, early in the dry period. Hygiene standards 
and practices at drying off – as outlined in detail in the CellCheck Farm Guidelines (pages 117-
119) – are essential to protect the udder health of the uninfected cow.
2. The second risk is of missing the opportunity to cure quarters that were infected at the 
point of drying off, to maximise cure rates before the next lactation starts. A very common 
question is “how do I know which ones are the infected animals?”. There are many criteria that 
need be considered when making these decisions, including milk recording results and milk 
culture results. Even with all this information on hand, further questions remain such as 
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“How many milk recording results do I need to have and how close to drying off do they need to be?” 
and “at what cow SCC level should I consider using antibiotic dry cow therapy?”. The reality is that 
there are still many unknowns, and not all these key questions can yet be reliably answered. 
Everyone agrees about the key role of milk recording in helping with this decision. At this 
point however, different countries have adopted different herd and cow-level thresholds for 
deciding to treat with antibiotics at drying off. This highlights that there isn’t one, simple 
answer to this question. Future research, both Irish and international, should help answer 
some of these questions, direct good and appropriate decision-making and help us to predict 
the outcomes and manage some of the risks involved. 
Is a selective dry cow strategy suitable for all herds?
Currently the CellCheck Farm Guidelines for Mastitis Control, including Management Note C, 
outline some of the essential herd and cow-level information that must be available in order to 
safely consider adopting a selective dry cow therapy approach. 
Selective dry cow therapy can be considered in herds where:
•	 There are good clinical mastitis records, milk culture results and at least 4 milk recordings in 
the current lactation for each cow
•	 Bulk tank SCC is consistently <200,000 cells/mL
•	 Clinical mastitis in the herd is <2% over the last 3 months prior to drying off
•	 The recent infection rate in the herd is consistently <5%, as indicated on the CellCheck Farm 
Summary Report
•	 Hygiene standards at drying off and management of dry cows are excellent.
Within these suitable herds, antibiotic treatment may not be required for individual cows that 
have had no somatic cell count result >100,000 cells/mL and no history of clinical mastitis, in 
this lactation. These cows should also be checked with a California Mastitis Test paddle prior to 
drying off. The ‘Milk Recording SCC’ profile, available on the ICBF website for all farmers that are 
milk recording, can be used to create a list of all cows with an SCC <100,000 cells/mL on all milk 
recordings, by setting the relevant filters.
All decisions around dry cow therapy should be made in consultation with a veterinary practitioner 
who has knowledge of the herd, its history and environment. Over time, as more research and 
technologies become available, these decision-making thresholds and recommendations may 
change, reflecting changes in our ability to predict infection and treatment outcomes. However, the 
fundamental requirements of good quality information, excellent hygiene and risk management 
will never change.
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Introduction
Antimicrobial resistance (AMR) is a fundamental one health challenge that is facing human health 
care and veterinary practitioners alike and demands good antimicrobial stewardship (AMS) as 
our collective response. The ability to make good antimicrobial (AM) prescribing decisions is a 
fundamental part of AMS and one aspect in which veterinary surgeons (VS) have the power to 
make a significant positive impact, as AM prescribing is such a common outcome of veterinary 
consultations. A three-month retrospective analysis of consultation data from the Small Animal 
Veterinary Surveillance Network (SAVSNET), found that AM use resulted from between 35.1 and 
48.5% of consults (Radford et al., 2011). Experience would suggest a similar picture exists within 
production animal practice.
The line of responsibility for the use of prescription-only veterinary medicines (POM-Vs) is clear 
and articulated in the Royal College of Veterinary Surgeons (RCVS) Code of Professional Conduct 
for Veterinary Surgeons (2012). The British Veterinary Association (BVA) policy on the Responsible 
use of antimicrobials in veterinary practice (2015) assumes that the primary responsibility for AMS 
lies with the veterinary surgeon. The common challenge of poor user compliance is not an excuse 
(Sawant et al., 2005), nor does it undermine the fundamental responsibility of VS for AMS on farm, 
as the gatekeepers to AM use.
We need to first better understand the factors that impact and influence our prescribing decisions 
before we can articulate a best-practice approach.
Towards a better understanding of AM prescribing decisions
The importance of non-clinical drivers
Antimicrobial prescribing decisions are complex. They are influenced by a broad range of intrinsic 
and extrinsic factors, of which the clinical findings are only one part. Clinical decision making is 
highly influenced by established belief-systems and experience. Fig. 1 summarises the range of 
factors that are at play.
Take home messages
•	 Veterinary surgeons are the gatekeepers of antimicrobial use on farm and need to actively 
exercise their responsibility for antimicrobial stewardship (AMS) in this area.
•	 Antimicrobial prescribing decisions are complex; we need to acknowledge and account for the 
full range of factors that may influence our choices.
•	 The principles of evidence-based veterinary medicine (EBVM) must be applied to establish a 
‘best-practice’ approach to prescribing as part of good AMS.
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Fig. 1 – Intrinsic and extrinsic factors influencing prescribing decisions in veterinary practice.
A 2018 Delphi study established an expert consensus of the behavioural drivers and barriers to 
achieving AMS in veterinary practice. Pre-existing antimicrobial prescribing patterns and behaviours 
(e.g. inappropriate, unnecessary or defensive prescribing) and client interactions were likely to have 
a greater impact on responsible AM use than clinical factors such as the case presentation or patient 
characteristics (Currie et al., 2018). The practice culture, attitude to the use of diagnostic tests and 
the infection control practices were also considered to be influential. 
Similar observations are well-established within the medical literature. A study which investigated 
GP prescribing for acute upper respiratory tract infections, found that the best predictor of AM 
use was the GPs prescribing habit, rather than clinical findings or patient factors, though these did 
have an effect (De Sutter et al., 2001). Patient or disease characteristics had no effect on compliance 
of AM prescribing with hospital guidelines on responsible use (Mol et al., 2006). Perhaps more 
worryingly, in the same study, de-escalation in response to culture and susceptibility (C&S) results 
was rarely practised, and these had no effect on compliance with AM use guidelines in cases of sepsis. 
The authors concluded that clinicians were adopting a defensive prescribing approach, prioritising 
perceived successful treatment above reducing AMR risk.
The risk of defensive prescribing
Defensive prescribing is common. It encapsulates the idea of prescribing antibiotics “just in case” 
and reflects an aversion to risk-taking and reflects problems in dealing with uncertainty (De Sutter 
et al., 2001). It is amplified by a concern for patient welfare and managing client expectations, 
and is influenced by the prevailing culture within a practice. It is a particular challenge when the 
decision not to prescribe may be perceived by the client as uncaring. Defensive prescribing does 
not represent good AMS, because it will drive unnecessary prescribing, increasing the risk of AMR 
development.
Within the production animal context, the low cost and widespread availability of antimicrobials 
on farms may be one contributory factor. Why take the risk of not prescribing AMs when presented 
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with a sick animal? The problem with this approach being self-perpetuating and the need for 
veterinary surgeons to take ownership of their responsibilities in this area has been described 
by myself and colleagues elsewhere (Tisdall et al., 2017): “When antibiotics are administered in 
cases where they are not required, self-cure and recovery is mistaken for treatment efficacy, and so 
experience reinforces the drive to prescribe in subsequent cases. This cycle needs to be disrupted 
in the mind of the farmer, but first in the mind of the prescribing veterinary surgeon, and this is 
uncomfortable and challenging because it involves uncertainty and perceived risk”. 
Establishing a ‘Best-practice’ approach to empirical prescribing
Best-practice prescribing may be described as the practical application of the principles of evidence-
based veterinary medicine (EBVM) to clinical antimicrobial treatment decisions. It should both 
be informed by the available evidence but also drive the acquisition of evidence. The absence of 
all the evidence, does not preclude best-practice, nor is it a justification for poor practice. More 
information on EBVM is available through the following links: http://www.ebvmlearning.org/ and 
https://bestbetsforvets.org . A best-practice approach will be considered around a series of questions 
that a practitioner should ask themselves before prescribing an AM. The primary focus will be on 
how to make good empirical prescribing decisions based on a clinical diagnosis and assumptions 
about the likely bacteria present at the point of first presentation. This is not to undermine the 
importance of C&S testing, which is generally under-used in farm animal practice and must become 
more common place, particularly where there is diagnostic uncertainty, when group treatments are 
being considered (e.g. metaphylaxis) or if AMR is anticipated.
1. What is the most likely diagnosis? 
The first step in a best-practice approach is to establish the most likely diagnosis. This should be 
based on a comprehensive clinical examination of animal alongside obtaining an accurate history of 
the case. Patient-side diagnostics may have a role to play in some cases.
2. Is antimicrobial treatment indicated: will it improve the prognosis?
Once the most likely diagnosis is established, the next question is whether antimicrobial treatment 
is needed. However, the most important question is not whether bacteria are present and causing 
disease, but whether the prognosis will be improved by AM treatment. In the human healthcare, 
prognosis-based scoring systems have been developed to guide AM prescribing (Hay et al., 2016). 
In contrast, in the farm animal context, though scoring systems exist (e.g. for bovine respiratory 
disease; BRD) (McGuirk, 2008), these tend to focus on diagnostic thresholds for treatment rather 
than prognosis. There is a clear need for further research in this area.
Confirmation of a bacterial condition does not automatically mean that antimicrobial therapy is 
indicated, because it is not simply the presence of bacteria that matters, but whether administering 
an antimicrobial will improve the prognosis for the case. A good example of this would be the 
treatment of toxic mastitis in cattle. Although most cases are caused by E coli, a review of the 
literature provides good evidence that antimicrobial therapy is unlikely to improve clinical outcome 
and that overall prognosis for survival is poor. At this stage it is important to consider other non-
antimicrobial treatments that might be more appropriate. In the same example, it is fluid therapy, 
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) and nursing case that collectively that really 
make the difference in terms of prognosis and patient outcome, rather than antimicrobial therapy.
3. What are the likely bacteria?
After establishing that antimicrobial therapy is likely to improve the prognosis, the next question 
focuses on establishing the likely causal bacteria. Within an empirical approach this will be based 
ONE HEALTH: Awareness to Action Antimicrobial and Anthelmintic Resistance Conference | 49
upon the clinical presentation and knowledge of typical C&S testing results for that presentation. 
Knowledge about which species of bacteria are typically associated with which body system as well 
as with certain types of infection is helpful here. It is also important to know whether the bacteria 
are likely to be gram positive or negative, aerobic or anaerobic. There are a few general “rules of 
thumb” that can be helpful, such as, that with increasing chronicity there tends to be a shift towards 
more gram positive and anaerobic causes.
4. Is AMR likely to be a factor?
It is important at this stage to consider whether AMR may be a factor both in the treatment of 
the case, but also in the impact of that treatment on promoting resistance in the microbiome. The 
presence of AMR may be more likely in certain presentations and particularly where there has been 
a history of recurrent antimicrobial courses. If it is considered likely that there is a risk of AMR then 
C&S testing must be carried out.
5. What is the narrowest spectrum antimicrobial that is likely to be effective?
Once the most likely causal bacteria and their characteristics have been established, good AMS 
practices dictate that the narrowest spectrum antibiotic that is likely to be effective should be 
selected and that the Highest Priority Critically Important Antimicrobials (HPCIAs) (e.g. 3rd/4th 
generation cephalosporins and fluoroquinolones) should not be chosen for first-line use. It is worth 
remembering that in some case the most appropriate antimicrobial will not always the one that 
has a specific license for that condition. As a baseline, knowledge of the following characteristics of 
the main antimicrobial classes is essential for prescribing well, and of these, the first three are of 
greatest practical importance.
•	 Spectrum of activity – The narrowest spectrum antimicrobial that will be effective should be 
selected, based on whether the class is predominantly gram positive or negative and aerobic 
or anaerobic in efficacy, and whether there is activity against mycoplamas. For certain classes 
(e.g. Penicillins, Cephalosporins and Macrolides) there are also therapeutically significant 
changes in spectrum across the class. It is worth bearing in mind that with the move from 
treating gram positive to gram negative and aerobic to anaerobic organisms, increasingly 
broader spectrum products will generally be required.
•	 Bactericidal or bacteriostatic – This should be considered in light of host immune status and 
case severity. It is worth remembering that for some classes, whether they are bactericidal or 
bacteriostatic is influence by the dose rate (e.g. Macrolides).
•	 Time- or concentration- dependant mode of action – This has an important bearing on both 
dose rate and course duration, but should be considered when managing cases of endotoxaemia. 
•	 Pharmacokinetics – The most important pharmacokinetic aspects to consider are route of 
administration and distribution to / penetration of the target tissues. Where possible options 
for systemic antimicrobial treatment should be avoided in favour of local application. This 
minimises exposure of the microbiome, particularly within the gastro-intestinal tract, to 
antimicrobials, reducing the selection pressure for AMR.
•	 Pharmacodynamics – Mechanisms of action and potential drug interactions.
6Other therapeutic considerations
Only once the characteristics above have been fully considered to identify a list of appropriate 
first line products, is it appropriate to refine selection based on secondary criteria such as ease 
of administration, milk and meat withdrawal times or the cost of treatment. Therapeutic 
appropriateness regarling the likely causal organism(s) must always come first when adopting a 
best-practice approach to prescribing.
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Early treatment, delayed prescribing and de-escalation
For certain conditions such as bovine lameness, there is good evidence that early and appropriate 
treatment significantly improves outcomes (Groenevelt et al., 2014). It is worth noting that the 
focus of this study was on therapeutic claw trimming rather than AM therapy. The largely positive 
early-treatment mentality carries the risk of inappropriate or excessive AM use, because a greater 
number of individual cases that may otherwise self-cure are unnecessarily treated. This risk is 
amplified in the case of group treatments such as metaphylaxis and prophylaxis. In the author’s 
view the latter of these is not an acceptable approach to AM use in production animal practice 
(e.g. routine antimicrobial footbathing for the control of digital dermatitis) (Tisdall & Barrett, 
2015). Conversely there may be a risk to animal welfare and overall treatment outcomes of delaying 
treatment, so careful case selection is required. 
Delayed treatment should be considered in cases, when following an initial clinical assessment, it 
can be established that postponing AM therapy to assess the response to conservative treatments 
(e.g. NSAIDs) is unlikely to have a detrimental effect on welfare or prognosis. It is particularly 
appropriate in conditions with a predominantly viral aetiology and where there is not an urgent 
treatment need. Following examples from the human field, this is being considered in cases of acute 
respiratory tract disease in calves with predominantly upper respiratory tract signs. C&S testing 
should form be part of this approach, allowing more targeted AM prescriptions and permitting de-
escalation to narrower spectrum products, or cessation of therapy, after the diagnosis is confirmed. 
A good example of this is in the management of bovine mastitis, with the increasing availability of 
on farm culture to distinguish between gram positive and negative pathogens. 
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Introduction 
Healthy, well grown, calves are crucial to the success of any calf rearing system. Two of the main 
factors which are paramount to maintaining healthy calves are hygiene and colostrum management. 
Attention to detail in calf rearing addressing ways to minimise the amount of pathogens a young 
calf is exposed to and maximising calf immunity, as well as reducing stress around weaning can 
contribute to reducing infection and disease thereby reducing the need for antibiotics. 
Importance of colostrum 
When the calf is in-utero there is no transfer of immunity from the dam to the calf, due to the 
structure of the placenta. Therefore it is essential that a calf is born into a clean environment to 
minimise the risk of exposure to disease. Immunity must be acquired passively by the calf from 
colostrum. Ensuring that the new-born calf receives sufficient high-quality colostrum as soon as 
possible after birth is widely recognised as being crucial to the animal’s subsequent health and 
well-being. Failure to implement a good colostrum management routine will result in many 
unfavourable consequences such as increased risk of disease and death, slower growth rates and 
a reduction in long-term productivity. Of course, any colostrum which is collected needs to be 
done in a very hygienic manner as poor hygiene practices can result in bacterial contamination of 
colostrum, and numerous studies have reported a negative association between colostrum bacterial 
content and absorption of antibodies. A survey was recently undertaken by Teagasc Moorepark on 
a representative proportion of commercial dairy farms and examined several factors associated 
with calf rearing (Barry et al., 2019). The results of this survey showed that the bacteria levels were 
highest on bottles and stomach tubes used to feed calves their colostrum. Therefore, clean feeding 
utensils are essential to minimise bacterial contamination and maximise the uptake of antibodies 
from colostrum.
Take home messages
•	 The colostrum 1, 2, 3 rule needs to be strictly adhered to – feed the calf the 1st milk the cow 
produces within 2 hours of birth and feed 3 litres
•	 Calves should be fed transition milk for at least four feeds after colostrum feeding
•	 Do not feed calves milk with antibiotic residues as it can contribute to the development of 
antimicrobial resistance
•	 A focus on good hygiene practices, adequate calf nutrition, suitable calf housing and focusing 
on areas to reduce stress all can contribute to reducing disease on farms reducing the need 
for antibiotics
•	 A vaccination schedule should be integrated into a bespoke farm herd health programme
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Once collected hygienically a good colostrum management routine can be easily remembered by 
implementing the following simple rule which was devised by Animal Health Ireland: 
Colostrum 1, 2, 3 – feed calves the 1st milk the cow produces, within 2 hours of birth and feed 3 litres
Colostrum quality
Colostrum is the first milk the cow produces, milking two to six are referred to as transition milk. 
Good quality colostrum is defined as colostrum with an Immunoglobulin G (IgG; antibody) content 
of >50 mg/ml. The quality of colostrum can be affected by many factors such as lactation number; 
older cows tend to have higher quality colostrum. However, the majority of heifers also produce 
colostrum with an IgG content > 50 mg/ml. Colostrum quality is also affected by the interval 
between calving and first milking, colostrum quality deteriorates if cows are milked for the first 
time 9 hours or longer after calving; volume of colostrum produced also has an effect - cows who 
produce a lower volume have higher quality colostrum. Breed, length of the dry period, diet during 
the dry period and calving time of year (cows that calved earlier in spring (Jan/Feb/Mar) or in 
autumn produced colostrum with higher IgG concentration than cows that calved in April/May) 
also impact colostrum quality. 
Colostrum quality can be quickly and easily tested by using a relatively inexpensive piece of 
equipment called a Brix refractometer. When using the Brix refractometer a value of 22% equates 
to 50 mg/ml. Therefore, values of 22% or greater represent good quality colostrum which is suitable 
to feed to calves for their first feed. If values are less than 22% the colostrum should not be fed to a 
calf as its first feed. Again, results from the Teagasc survey mentioned above showed that 21 % of 
colostrum samples tested were below the recommended threshold of 50 mg/mL. This reiterates the 
importance of testing colostrum to ensure the quality is sufficiently high to feed to calves.
Time of feeding colostrum 
Much international research work has been completed on the timing of colostrum feeding. In short, 
calves should be fed within the first two hours of birth as absorption of immunoglobulins is greatest 
during this time. By six hours of age a calf ’s ability to absorb immunoglobulins has halved and by 
24 hours of age it can no longer absorb any immunoglobulins from colostrum. Calves should be fed 
3 litres for their first feed, this equates to ~8.5% of their birth bodyweight. There is little difference 
between the methods of delivery be it using nipple bottle, bucket or stomach tube when giving 3 
litres, as long as the calf gets the adequate amount of good quality colostrum. 
Suckler calves should suckle within 2 hours of birth on their own or with assistance (if safe to do 
so) otherwise they may need to be given colostrum with a nipple feeder or stomach tube. Certain 
situations may arise where suckler calves have to be given colostrum by a nipple bottle/bucket or by 
stomach tube, for example if calves are too weak to suckle or have a difficult birth; or if the dam has 
a very pendulous udder making it too difficult for the calf to suckle.
Transition milk feeding
No further transport of IgG into the calf;s blood circulation system is possible 24 hours after birth. 
Nonetheless, transition milk (milkings two to six post-calving) fed subsequent to colostrum may 
have beneficial effects, as it contains a greater concentration of IgG than whole milk and antibodies 
remaining in the gastrointestinal lumen may provide local immunity against enteric pathogens. A 
Teagasc Moorepark study found that feeding calves transition milk for at least 2 days after their 
colostrum feed reduced their odds of being assigned a worse eye/ear and nasal score when they 
were subsequently continually health scored. Rather than depending on antimicrobials to treat 
sick calves the implementation of a good colostrum management plan, followed by transition milk 
feeding can reduce the risk of calves becoming ill and requiring treatment. 
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Milk feeding
Good nutrition is fundamental to animal health, welfare and productivity. Traditional milk feeding 
systems for dairy calves have been based on daily feeding rates of 8 to 10% of body weight (~4 litres/
day). These ‘restricted’ feeding systems were intended to encourage the calf to eat a greater quantity 
of concentrate feed from a young age. However, they seriously limit growth potential as they only 
allow 20-30% of biologically normal growth and are detrimental to calf health and welfare. A higher 
plane of nutrition facilitates physiologically appropriate growth rates, better immune function, and 
lower incidences of disease and mortality. In a recent Moorepark study, calves were fed 4 litres 
(~10% of birth bodyweight) or 6 litres (~15% of birth bodyweight) of milk for the pre-weaning 
period. Calves fed 4 litres of milk were lighter at five weeks of age than those fed 6 litres. At five 
weeks of age the reticulorumen is still underdeveloped and calves fed a restricted quantity of milk 
are not capable of increasing intake of starter concentrate and forage to a degree that they can fully 
compensate for the lower supply of energy from milk. Feeding calves a greater volume of milk tends 
to reduce the number of days taken to reach a target weaning weight. Furthermore, there was no 
difference in incidences of diarrhoea between calves fed 4 litres or 6 litres of milk. Results from 
the Teagasc Moorepark survey showed that over half of participants feed their calves’ waste milk 
(non-saleable milk, which included antibiotic residues). This is a practise which has been shown to 
contribute to the development of antimicrobial resistance, particularly when antibiotic residues are 
present. While this practise is not prohibited and also reported in other countries, farmers need 
to realise the implications for its contribution to antimicrobial resistance on-farm and efforts to 
eliminate its use when feeding young calves need to be implemented. 
Calf health
The 2016 All Ireland animal disease report shows that the leading cause of death in young calves 
in Ireland in the first month of life is scour and the most frequently found pathogens in these 
scour infections are Cryptosporidium (a protozoan parasite) and rotavirus. Many calves who died 
in the first month of life were found to have failure of passive transfer. The leading cause of death 
in calves over 1 month of age was respiratory disease. A recent Teagasc study (Earley et al., 2019) 
reported similar findings and it also showed that although Ireland is relatively similar in terms 
of antibiotic use in calves, to other European countries, the use of HP CIA (the antibiotics most 
important in human medicine) were widely used in youngstock in Ireland. Neonatal calf scour and 
calf pneumonia remain the leading causes of morbidity and mortality in youngstock on Irish farms. 
A focus on control and prevention of these diseases is a major opportunity for reducing antibiotic 
usage but also improving calf health and welfare. 
The decision to use an antibiotic in calf disease is not straightforward. A complicated mix of bacterial 
and non-bacterial pathogens, as well as a lack of readily available, reliable calf side diagnostic tests, 
makes the decision on antibiotic use in sick calves difficult (Hyde et al., 2019). Therefore, a focus on 
standardising treatments and criteria for treatment of sick calves is required as part of the on-farm 
herd health programme. This will allow for more targeted use of antibiotics in the treatment of calf 
disease. Broadly speaking the treatment of calf scour focuses on providing oral rehydration solutions 
and continuing to feed milk where possible. Antibiotics do not form the mainstay of treatment of 
most cases of uncomplicated calf diarrhoea. It is essential to work with your veterinary surgeon 
to develop a standard operating procedure (SOP) for treatment of routine calf scour cases and calf 
pneumonia cases to ensure antibiotic use is targeted to cases that need it and clear criteria are 
outlined for cases that need veterinary intervention.
 
Approach to control and prevention of a calf scour or pneumonia 
The approach to control of scour cases is broadly similar regardless of the exact pathogen present; 
the same is true for BRD, control and prevention have a similar approach regardless of the specific 
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viruses or bacteria involved. It is essential to work with your veterinarian to promptly investigate 
any group level problem so risk factors can be identified, and control strategies initiated quickly. 
It is useful to keep disease records to properly assess any patterns and help guide the correct 
diagnostics and treatments on farm.
The 2 main principles of control of any infectious disease control revolve around:
1. Reduce Infection Pressure (minimize the number of pathogens the young calf is exposed to)
•	 Maintain strict standards of hygiene throughout calf rearing; this includes the calving 
pen, calf pens/calf housing. Provide adequate bedding and replace regularly
•	 Calves under 3 weeks old need to be kept warm so a clean, dry bed is essential. Cold 
calves who need to use energy to keep warm are more likely to become sick
•	 Have a standard cleaning procedure for cleaning and drying of feeding equipment
•	 Keep calves in age-matched groups, avoid mixing of calves of different age ranges
•	 Feed the youngest calf on the farm first and work through to oldest. Handle sick calves after 
finishing handling the healthy ones
•	 Have a hospital/isolation facility, wash hands and clothing after handling sick calves
•	 Thoroughly clean and disinfect calving and calf pens with a disinfectant effective against 
Cryptosporidium when appropriate and ideally leave free of animals for 3-4 months before 
the next calving season
•	 Calf housing weaknesses can be a major risk factor for calf disease. Review the adequacy 
of calf housing – in terms of ability to thoroughly clean, if there is adequate drainage, if 
there is adequate floor and air space per calf. The key elements of a calf housing assessment 
include:
o Assessment of supply of fresh air and ventilation within the shed; this is important to 
remove pathogens from the air and facilitate maintenance of consistency of fresh air 
at calf level. Ensure no draughts at calf level
o Assessment of moisture control and adequacy of drainage. Attention to removing 
excess moisture via having an appropriate fall in the floor, not having leaking drinkers, 
keeping automatic feeders drained and away from the straw bedding all may contribute 
to this.
o Assess stocking rate: have appropriate amount of floor space and air space per calf 
2. Maximize the Immunity of the Calf
•	 Ensure colostrum management and attention to detail is excellent as outlined above 
•	 Maintain calf on adequate level of nutrition to help fight disease – as detailed above
•	 Good stockmanship to identify, isolate and treat cases of disease early 
•	 Try to follow a consistent calf management routine, feeding at the same time each day
•	 Minimize stress associated with disbudding/dehorning – do not do this stressful 
procedure at the same time as anything else such as weaning or group changes
•	 Engage with your veterinarian to identify key areas to target to improve calf health and 
integrate calf health into a routine herd health plan that is reviewed and updated annually
•	 In conjunction with your veterinarian devise an appropriate vaccination strategy to meet 
the key needs of the farm
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Young calves with appropriate nesting scores         Assess drainage and bed quality
Weaning
Weaning stress has an adverse effect on the immune system, making calves more susceptible to 
disease, particularly pneumonia. It is essential for the health and performance of calves to minimise 
stress around weaning by using appropriate weaning procedures (Lorenz et al., 2011). It is vital 
that a calf has an adequately developed rumen in order to successfully transition to a non-milk 
diet. This should be determined by intake of concentrate feed rather than weight or age. Weight 
monitoring is useful to assess performance during the pre-weaned phase and to assess for growth 
checks around weaning. In addition to the stressful process of weaning for the calf, this time often 
co-incides with other stressful events, such as transport and co-mingling. Weanling pneumonia, 
whether in dairy or beef calves, is a classic multi-factorial disease. Healthy cows and calves may 
carry some of the pneumonia causing pathogens without showing any signs of clinical disease. 
Unfavourable environmental conditions and other stress factors contribute to compromising of the 
immune system and respiratory defences, predisposing to viral infection of the lungs which is then 
followed by bacterial infection, which causes the main damage to the lungs and can be irreversible. 
The following management practices at weaning to help prevent weanling pneumonia: 
•	 Access to a palatable calf starter and free access to water from a few weeks of age help 
the rumen develop properly. It is essential that calves are weaned based on intake of 
starter (ideally 1kg per day consistently or more for group fed calves) to ensure they 
are capable of being a functional ruminant once weaned
•	 For suckler calves; concentrates should be introduced at least 4-6 weeks prior to 
weaning, and calves should be eating at least 1kg of concentrates per day at weaning. 
Concentrate supplementation should continue for at least 2 weeks after weaning
o  In larger herds calves should be weaned gradually by removing a small number of cows 
from the herd every five days
•	 If beef suckler calves are to be housed, ideally wean 3 weeks before planed housing 
and again ideally wean in good weather conditions
•	 If dehorning and castration have not been carried out by the time of weaning they 
should be avoided for at least four weeks prior to or four weeks after weaning. Try to 
keep stressors to 1 at a time
•	 Housing should be appropriate for the stock type and number, it should be clean, dry 
and well ventilated with enough feed and water trough space. Housing stressors such 
as poor ventilation, draughts and overcrowding are risk factors for pneumonia
•	 Ensure that vaccination is completed in advance of the period of stress associated with 
weaning
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Vaccinations
Vaccination is a very useful way to help improve immunity to certain diseases and is a major tool in 
the armoury in the fight against AMR and reducing antibiotic usage. Vaccinations do not eliminate 
disease and do not remove the need for proper care and attention to be paid to all aspects of calf 
management. Every farm should have a vaccination programme, designed bespoke to the farm in 
conjunction with the attending veterinarian to help prevent calf disease. Vaccination programmes 
reduce disease severity and improve immunity if administered correctly to animals that are able to 
respond appropriately to the vaccine. Scour vaccinations should be administered to cows in advance 
of calving and are useful to improve colostral antibodies to certain common scour-causing pathogens 
such as rotavirus, coronavirus and E.coli. An investment in these vaccines mean that careful attention 
must be paid to ensuring the calf gets fed colostrum and transition milk to ensure the benefit of the 
vaccine is delivered to the calf. 
There are many combinations of pneumonia vaccines on the market with many different details 
such as cost, timing of use, and duration of protection. Your veterinarian is best placed to devise a 
farm specific vaccine selection and appropriate vaccine schedule for each farm. Most calf pneumonia 
vaccine protocols involve either intranasal or injectable vaccines and there are many combinations 
and options available. Clostridial vaccination programmes are also usually started as calves. It is 
vital irrespective of the programme that vaccines are stored and administered as per manufacturer’s 
instructions including being given at the right time, at the right dose and route of administration 
and right interval between primary and booster (if required). It is also very important that vaccines 
are not given to sick calves as sick, or very stressed calves will not respond appropriately to the 
vaccine. In addition, vaccination should not take place at the same time as any stressful event for 
the calf such as disbudding or group changes. A vaccination schedule should be part of a holistic and 
comprehensive approach to calf health.
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Introduction
Biosecurity is paramount to the healthy production of animals. A standardised tool for assessing 
biosecurity (BiocheckUGent) is being used on Irish pig farms to assess and improve national herd 
biosecurity. Preliminary results will be presented in this paper. Biosecurity at farm includes all 
measures taken to minimise the risk of introduction and spread of pathogens on the farm. By 
taking these biosecurity measures and performing efficient management, on-farm animals are 
protected against both endemic and epidemic diseases (Amass and Clark, 1999). Biosecurity can be 
divided into external and internal biosecurity. External biosecurity focuses on the contact points of 
the farm with the outside world and aims to prevent pathogens entering or leaving the farm. This 
applies both to exotic diseases (e.g. African Swine Fever), as well as to endemic diseases (e.g. PRRS) 
(Ribbens et al., 2008). All measures taken to limit or stop the spread of pathogens within a farm are 
covered by internal biosecurity (Laanen et al., 2013).
The implementation of biosecurity measures has also been shown to have other positive effects. 
For example, in several studies with pigs, biosecurity showed a positive correlation with production 
(such as daily growth) (Rodrigues da Costa et al., 2019) and the profitability of the farm (Laanen 
et al., 2013). Along with this, the use of antibiotics can be greatly reduced (Laanen et al., 2013; 
Postma et al., 2016), which, consequently, will reduce antibiotic resistance (Chantziaras et al., 
2014). Biocheck is a risk-based scoring system developed by the University of Ghent to evaluate the 
quality of on-farm biosecurity in an scientific and independent way (https://www.biocheck.ugent.
be/). External and internal biosecurity are divided into several sections (Table 1) for both pig and 
poultry farms. Private veterinary practitioners (PVPs) were trained in 2018 on how to use this tool 
through the Targeted Advisory Service on Animal Health (TASAH) under the Rural Development 
Programme (2014-2020). 
As of 26th September 2019, 86 pig units have used this service and have been reviewed in terms of 
their biosecurity. The preliminary results indicate that external biosecurity (measures to prevent 
disease entering the unit) scores are higher than internal biosecurity (measures to prevent disease 
spreading within the unit) (Figure 1). Some of the areas with the lowest biosecurity scores are the 
management of feed, water and equipment coming into the farms; the measures implemented 
between compartments to decrease disease transmission and cleaning and disinfection procedures 
(Fig.2).
Take Home messages
•	 The internal biosecurity of Irish pig farms requires improvement.
•	 Improving the cleaning and disinfection procedures on farm and implementing measures 
to decrease disease transmission between compartments/rooms will improve the internal 
biosecurity scores and consequently, pig health status of the farm
•	 A clear separation between the clean and the dirty (risky) sections of the farm will improve 
internal and external biosecurity. All inbound and outbound traffic that serves multiple 
companies (feed, manure, deadstock collectors) should always be led via the dirty road.
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Table 1. External and Internal biosecurity components of BiocheckUGent tool for pigs and 
poultry farms.
Fig. 1. (left) Graph showing the scores per unit for 
biosecurity (external, internal and overall) for the 86 
pig units assessed. Tick line is the median (half of the 
units assessed have scores lower than this line when 
the other half have scores higher than this line).
Fig 2. (below) Graph showing the scores per unit for 
the components of external (left panel) and internal 
(right panel) biosecurity for the 86 pig units assessed. 
Tick line is the median (half of the units assessed 
have scores lower than this line when the other half 
have scores higher than this line). 
 Pigs  Poultry
External Internal External Internal
Purchase of animals and semen Disease management Purchase of one day Disease    
  old chicks management
Transport of animals, removal of Farrowing and Depopulation of Cleaning and
manure/dead animals suckling period broilers disinfection
Feed, water and equipment supply Nursery unit Feed and Materials and
 management water supply measures between
   compartments
Personnel and visitors Fattening unit Removal of manure
 management and dead animals
Vermin/bird control Measures between Entrance of visitors
 compartments, and the and personnel
 use of equipment
Environment and region Cleaning and disinfection Supply of materials
  Infrastructure an
  biological vectors
  Location of the farm
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Conclusions
The internal biosecurity of Irish pig farms requires improvement. This will prevent disease 
spread within the unit and consequently reduce disease prevalence for endemic diseases such as 
salmonellosis, PRRS, colibacillosis and swine dysentery.
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Introduction. 
Approximately 90% of antimicrobials prescribed to livestock in the European Union (EU) are given 
by oral administration (European Medicines Agency, 2017) either as medicated feed or in drinking 
water. Oral medication has significant advantages in terms of labour and ease of administration 
and is often the only practical method of treating large groups of animals e.g. poultry. Oral 
administration also has the advantage of less carcass damage compared to injection methods, 
and generally has shorter withdrawal times than veterinary medicines administered by injection. 
(European Medicines Agency, 2019) However, oral medications present challenges in terms of 
ensuring that the antimicrobial agent being delivered via the feed or water is mixed homogenously 
and that there is no carry over of drug residues to the next unmedicated batch of feed or water. 
Moreover, it is impossible to ensure that each animal receives the correct therapeutic dose with 
medicated feed given the variability between animal intakes and the fact that sick animals are likely 
to eat less. The delivery of antimicrobials in the feed may affect palatability and result in reduced 
intakes with knock on effects in terms of animal performance. Oral medications have increase 
risk of been excreted via faeces and causing environmental contamination. Many studies have 
demonstrated that oral medication of animals leads to much higher development of AMR (Bibbal, 
et al., 2007) (Catry, et al., 2010) (Checkley, Campbell, Chirino-Trejo, Janzen, & Waldner, 2010) 
and given the link between oral medication and AMR the use of routine oral medication has been 
questioned. (Catry, et al., 2010)
Take home messages.
•	 The use of oral antibiotics in feed and water in the intensive production sectors for 
prophylaxis (preventative treatment of healthy animals) and metaphylaxis (treatment of 
healthy cohort animals following detection of clinical disease in the group) is a key driver for 
the selection and dissemination of antibiotic resistant bacteria.
•	 New legislation being introduced in 2022 aims to reduce the quantity of antibiotics being 
used in food producing animals with an overarching goal of protecting human health and 
slowing the emergence of Antimicrobial resistance (AMR). 
•	 AMR is a concern in pigs and poultry in Ireland, antibiotic use drives antimicrobial 
resistance. 
•	 Available data indicates that 66% of all veterinary antibiotics used in Ireland are given orally 
(in-feed/water/top dressing).
•	  In-feed medication creates numerous challenges in relation to prudent use of antimicrobials. 
It frequently results in the treatment of all the animals in a group rather that only targeting 
the animals that require treatment as well as resulting in prolonged durations of treatment
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Veterinary Antibiotic Use in Ireland.
Antibiotic sales in Ireland are relatively static at around 100 tonnes of active ingredient per annum. 
The population adjusted sales, expressed as mg of antibiotic sold per population correction unit 
(PCU) show a slight decline in usage for Ireland from 51.6 mg/PCU in 2016 to 46.6 mg/PCU in 2017. 
(European Medicines Agency, 2017). However, it is highly likely that this decrease is accounted for 
by the increase in dairy cattle population.
The current sales of antibiotics are shown in Fig 1 below.. Of significant concern is that over 66% of 
antibiotics are administered via the oral route, either in drinking water, as medicated feed or as top 
dressing. The vast majority of premix is used to produce medicated feed for pigs. While it is currently 
not possible to determine exactly where oral animal remedies are used, current research suggests 
that approximately 10 tons of oral antibiotics are used in the pig sector and approximately 4 tonnes 
are used in the poultry sector. It will require further work to determine the usage of the remaining 
19 tonnes. Given the lower body mass of pigs compared to the bovines, and the large number of 
bovines in Ireland it is highly likely that the Mg/PCU for the pig sector will be considerably higher 
than 46.6mg/PCU.
Fig 1. HPRA 2018, Report on consumption of veterinary antibiotics in Ireland during 2016
A new AMU database for the pig sector is currently being developed by the Department of 
Agriculture and the Marine DAFM. This database will allow pig farmers to report their population 
and antibiotic usage data on a quarterly basis. The reports from this system will help pig farmers to 
benchmark their antibiotic usage against the industry average. Anecdotal evidence from the poultry 
sector suggests that antibiotic usage in this sector is declining, and DAFM are currently working to 
produce a national AMU figure for the broiler sector. 
Future changes.
On the 28th of January 2022, two new EU regulations will apply, Regulation (EU) 2019/4 on the 
manufacture, placing on the market and use of medicated feed and Regulation (EU) 2019/6 on 
veterinary medicinal products. Both of these new regulations are very focused on AMR and will 
require significant change in how antibiotics are used. The use of antibiotics to compensate for 
sub-optimal husbandry is prohibited and routine prophylactic use of antibiotics in animals will 
not be allowed, Metaphylactic use, that is treating a group of in contact animals when disease has 
been diagnosed, will only be allowed if the risk of spread of infectious disease is very high. The 
Commission will also be able to restrict certain categories of antimicrobials for use only in humans. 
The overall focus of the new regulations is to protect human health, as well as animal health and 
welfare whilst ensuring tighter controls on the use of antimicrobials and to reduce the amounts 
used in animal production systems.
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Introduction
Grazing cattle and sheep are naturally exposed to gut worms (gastrointestinal nematodes). A large 
number of different gut worm species can infect cattle and sheep but most follow a similar life 
cycle with both free-living and parasitic phases (Fig. 1). Eggs laid by adult female worms in the 
gastrointestinal tract are passed out with the dung. The eggs hatch to L1 larvae which feed on 
microbes in the dung. The L1 stages develop to L2 stages (which continue to feed in the dung) and 
subsequently to L3 (infective stage). The L3 migrate out of the dung onto the grass where they can 
survive for many months until ingested by grazing cattle or sheep. Once ingested, they travel to 
their preferred site of infection in the gut where they further develop into mature adults which lay 
eggs. The majority of gut worms that infect cattle will not infect sheep and vice versa. The most 
important gut worms infecting cattle 
in Ireland are Cooperia and Ostertagia 
species while the most important 
infecting sheep are Nematodirus, 
Teladorsagia and Trichostrongylus 
species. Gut worms can cause 
disease including scour and ill-thrift 
in naïve calves and lambs but more 
commonly they are associated with 
appetite suppression and sub-clinical 
disease resulting in reduced growth 
rates. Worm larvae accumulate on 
pasture over the grazing season and 
consequently, worms are generally a 
greater problem in the second half of 
the grazing season. 
Take home messages
•	 Gut worm infection negatively impacts the performance of grazing lambs and calves.
•	 In grass-based production systems good gut worm control is currently highly dependent on 
the availability of effective wormers (anthelmintics).
•	 This approach is threatened by the development of anthelmintic resistance. This is the ability 
of gut worms to develop resistance to the wormers used to control them. 
•	 Resistance to benzimidazole (1-BZ: white wormer), levamisole (2-LV: yellow wormer) and 
macrocyclic lactone (3-ML: clear wormers) has now been identified on Irish cattle and sheep 
farms.Producers should implement sustainable worm control strategies that delay the further 
development of anthelmintic resistance.
Fig 1. Gut worm lifecycle.
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Control of gut worms
Control of gut worms is generally achieved by the administration of broad-spectrum anthelmintics 
(wormers). Despite the large number of anthelmintic products on the market, there are currently 
only 3 classes of wormer licenced in Ireland for the control of gut worms in cattle and 5 classes of 
wormer licenced in Ireland for the control of gut worms in sheep. These classes are 1) benzimidazole 
(commonly known as white wormers (1-BZ)), 2) levamisole (commonly known as yellow wormers (2-
LV)) 3) macrocyclic lactones (commonly known as clear wormers (3-ML)), 4) an amino-acetonitrile 
derivative (orange wormer 4-AD) and 5) spiroindole (purple wormer 5-SI). The latter two classes 
are licenced for use in sheep only and are veterinary prescription-only medicines. The product 
containing spiroindole is a combined formulation containing both a spiroindole and abamectin, 
which belongs to the 3-ML class of anthelmintics.
Table 1. Anthelmintic classes for the control of gut worms in cattle and sheep.
 
Anthelmintic resistance in Ireland
Anthelmintic resistance refers to the ability of worms to survive a dose that should kill them. 
Anthelmintics from different classes (1-BZ, 2-LV, 3-ML, 4-AD or 5-SI) have different modes of 
action. However, within the same class all products share the same mode of action and therefore 
when resistance develops to one product within a class generally other products in the same class 
are also affected. Anthelmintic resistance is a heritable trait which means resistant worms pass 
on genes conferring anthelmintic resistance to their offspring. When animals are treated with 
an anthelmintic at the correct dose rate, all susceptible worms are killed allowing only resistant 
worms to survive which results in resistant worms making up a greater proportion of the worm 
population in subsequent generations. Therefore, the continuous use of anthelmintics can lead to 
the development of anthelmintic resistance. For that reason it is important that anthelmintics are 
used appropriately to help slow the development of anthelmintic resistance. Anthelmintic resistance 
can be diagnosed on-farm by a faecal egg count reduction test (FECRT). This involves collecting 
dung samples from 10 to 20 randomly selected animals and determining the faecal egg count for 
each one. Animals are then treated with the product to be tested. Dung samples are collected from 
Anthelmintic Common Chemical Stages Species
class name ingredient affected
Benzimidazole White Albendazole Eggs, Larvae, Adults Cattle and sheep
(1-BZ)  Fenbendazole
  Oxfendazole
Levamisole Yellow Levamisole Adults Cattle and sheep
(2-LV)
Macrocyclic Clear Doramectin Larvae, Adults Cattle and sheep




Amino-acetonitrile Orange Monepantel Larvae, Adults Sheep
derivative
(4-AD)
Spiroindole Purple Derquantel Larvae, Adults Sheep
(+ Abamectin)  (+ abamectin)
(5-SI)
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the same animals after treatment (7 days post-treatment for levamisole; 14 days post-treatment 
for benzimidazole and macrocyclic lactone) and the egg count is again determined. The reduction 
in egg count after treatment is a measure of the effectiveness of the anthelmintic treatment. A 
fully effective anthelmintic dose reduces egg count to zero after administration. If the egg count 
reduction is less than 95%, then anthelmintic resistance is considered to be present (Coles et al., 
1992). 
The extent of anthelmintic treatment failure on both dairy calf to beef farms and sheep farms in 
Ireland has been investigated. For cattle, a faecal egg count reduction test was carried out with 
benzimidazole (n=15), levamisole (n=11), ivermectin (n=16) and moxidectin (n = 11). For sheep, 
group faecal egg counts were conducted before and after anthelmintic treatment of lambs with 
benzimidazole (n = 550), levamisole (n = 316), avermectin (n = 405) and moxidectin (n = 163) 
(Keegan et al., 2017). In each case the reduction in faecal egg count after anthelmintic treatment 
was determined and results are shown in Fig 2.
Fig 2. The percentage of dairy calf to beef and sheep farms where anthelmintic treatment 
failure was detected i.e. treatment did not reduce the faecal egg count by at least 95%.
Strategies to manage gut worms
Given the evidence for widespread anthelmintic resistance on both cattle and sheep farms 
in Ireland it is important that sustainable strategies to manage gut worms and to delay 
the further development of anthelmintic resistance are implemented. This will involve a 
combination of grazing management and rational use of anthelmintics.
Grazing management
•	 Where possible keep the cleanest grazing, such as forage crops, reseeded ground or hay/
silage after grass, for the youngest, most naïve animals. 
•	 Calves or lambs can be grazed ahead of older animals in a ‘leader-follower’ system. 
•	 Mixed or sequential grazing of cattle and sheep will reduce the worm challenge for each 
as the majority of worms that infect cattle will not infect sheep and vice versa. 
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•	 Make sure that anthelmintic treatments do not coincide with the movement of animals 
to lowly infected pastures i.e. do not ‘dose and move.’
•	 The impact of gut worms is lessened when animals are well-fed so ensure that all animals 
receive adequate nutrition. 
• Use of anthelmintics
•	 Only use anthelmintics when necessary based on reliable performance indicators such as 
average daily live weight gain or on herd-level or flock-level faecal egg count. As such, 
monitoring for gut worms is important and should be an integral part of a herd or flock 
health strategy. Young stock in particular should be monitored for signs of disease such 
as scour and lack of thrive that may indicate a problem with gut worms. Worm burden 
can also be monitored using faecal egg counts. In calves, a faecal egg count of greater 
than 200 eggs per gram may have an impact on performance and may indicate a need 
to treat for gut worms. In lambs a faecal egg count of greater than approximately 600 
eggs per gram may have an impact on performance and may indicate a need to treat for 
gut worms. 
•	 It is important to use an effective product and determining which anthelmintic classes 
are working on the farm is the first step in ensuring the right product is used. Discuss 
how to test which anthelmintic classes are working on your farm with your veterinarian. 
•	 It is important that the correct dosing technique is used and that the animals are treated 
according to the manufacturer’s instructions and dose rates. Check that the dosing 
equipment is delivering the correct amount before you treat. If possible weigh the animals 
to be treated or select and weigh a few of the biggest animals in the group to determine 
the dose rate and dose to the weight of the heaviest animal. If there is a large variation 
in live weight in the group then consider splitting the group based on weight and then 
determine the weight of the biggest animals in each group and dose accordingly. 
•	 Avoid the continual use of wormers from the same class and avoid the use of combination 
wormer/flukicide products. 
•	 For lambs, consider the use of one of the new classes of anthelmintics (orange or purple 
class) once in later summer to remove any resistant worms that may have built up from 
previous treatments.
•	 Older stock has generally developed good immunity to gut worms. Only treat individual 
older animals with anthelmintics on the basis of demonstrated need.  For example, 
mature ewes should not require dosing for gut worms 
•	 A good biosecurity protocol for all bought-in animals should be implemented. Animals 
should be treated with anthelmintic and housed for 48 hours. They should then be 
turned out to contaminated pasture recently grazed by cattle or sheep.
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Introduction
Lameness in sheep is common and is a well-known problem for sheep farmers. In the vast majority 
of cases the primary causes are footrot, interdigital dermatitis and contagious ovine digital 
dermatitis (CODD). These diseases are all caused by bacteria in association with host, management 
and environmental influences and as such antimicrobials have played and are likely to continue to 
play an important part in their control. Lameness has consistently been identified as a major cause 
of poor welfare, and in some of the stages of production has been considered the most significant 
cause of poor welfare. It is also associated with poor production resulting in fewer lambs born, 
reductions in growth rates and reductions in wool growth and milk production. In the UK and 
Ireland eradication remains impractical but there remain effective strategies for control. Recent 
efforts have focused on managing lameness to low levels using a combination of methods including 
the prompt, targeted antibiotic treatment of individual infected sheep. 
Interdigital dermatitis and footrot
Interdigital dermatitis and footrot (Figure 1) are primarily both caused by Dicehlobacter nodosus 
a Gram-negative, obligate anaerobe. The agent Fusobacterium necrophorum (also a Gram negative 
organism) is commonly found on pasture and it can (and frequently does) invade infected 
feet secondarily and can make the clinical signs worse. Dicehlobacter nodosus usually infects the 
interdigital skin in the first instance and favours traumatised skin. Prolonged soaking of the skin in 
warm wet under foot conditions serves to soften and macerate the interdigital skin, favouring the 
bacteria, as does the damage caused by rough, poached or stony ground. Infected sheep spread the 
infection by transferring infective bacteria from the foot lesion to the pasture or soil whereby a new 
host can become infected through secondary transfer onto similarly traumatised interdigital skin. 
Interdigital dermatitis then can develop into footrot through bacterial migration and breakdown of 
the hoof horn resulting in delamination and underrunning. 
Take home messages
•	 The ‘Five Point Plan’ is a useful and responsible framework to control lameness and reduce 
the use antimicrobials in the control of lameness in sheep. 
•	 Don’t be frightened of using antibiotics but use them well – ‘prompt appropriate treatment’. 
•	 Use non-antibiotic strategies to prevent and control infection. 
•	 Blanket treatment with antibiotics is rarely (if ever) necessary. 
•	 Antibiotics should not be used in footbaths. 
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Fig. 1. A foot with interdigital dermatitis (L) and a foot with footrot (R). 
Treatment and control
One approach to treatment and control is the Five Point Lameness Reduction Plan. This was 
developed at FAI Farms in Oxfordshire (Clements and Stoye, 2014), and was designed specifically 
for footrot, although many of the principles also crossover for the control of CODD. It is only one 
way to approach lameness control on farms and not the way, but it can provide a useful framework 
within which to work. 
The five points of the control plan are: prompt treatment, vaccinate, cull, avoid and quarantine. 
The elements are designed to work concurrently to reduce pathogen load, boost natural immunity 
and remove potentially more genetically susceptible individuals thus building a genetically more 
resilient flock. 
1. Prompt treatment
Prompt treatment of infected sheep is one of the main stays of this plan, and for which there is some 
of the strongest evidence. Several studies show that prompt treatment of sheep with footrot using 
parenteral antibiotics (with or without topical antibiotic foot spray) leads to more rapid healing and 
a return to production, a reduction in spread, and over time a lower prevalence of disease within 
the flock. In addition, refraining from therapeutic foot trimming leads to better cure rates, faster 
recovery and potentially a reduction in the spread of infection. 
There are not many studies examining foot bathing as a specific controlled intervention, and it has 
come under attack in recent years as an intervention on sheep farms. This may be partly due to the 
fact that it is possible for the prevalence of foot lesions to actually rise after foot bathing, which may 
be as a result of the gathering of sheep in order to put them through the footbath. If foot bathing is 
done well it can aid control (Witt and Green, 2018) but it needs to be viewed as one component of 
footrot control and not the only component. 
As to what to put in the footbath, formalin is frequently used. However, it is carcinogenic and at 
concentrations over 5% can damage the interdigital skin. Other chemicals have been used with 
varying efficacy and some e.g. copper sulphate can be damaging to the environment if not disposed 
of carefully and there is a risk of toxicity to some breeds of sheep through accidental ingestion. 
Reportedly, many producers find zinc sulphate effective at a 10% concentration. There is little 
published evidence for the efficacy of this approach in the UK and Ireland. However, recent work 
carried out in Australia in an experimental flock has shown good efficacy with zinc sulphate when 
used as a walk-through solution on a weekly basis to prevent interdigital dermatitis (Allworth and 
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Egerton, 2018). To help improve the evidence base, further work is currently ongoing at Nottingham 
to investigate the efficacy of commonly used foot bathing chemicals. Antibiotics have historically 
been used in footbaths, however, there is no antibiotic licensed to be used in this way, effective doses 
have not been robustly established and the presence of organic matter and debris could facilitate the 
development of resistance. In addition, in 2017 the Sheep Veterinary Society published guidelines 
on the responsible use of antimicrobials in sheep, highlighting the inappropriateness of the use of 
antibiotics in this way strongly indicating this as irresponsible use (SVS, 2017) . 
On some farms it may not be feasible to build in a strategy of prompt clinical treatment as a mainstay 
to footrot control. On hill farms for example it is frequently impossible to identify lame sheep and 
to then catch them for treatment and so there may be a greater reliance on other control methods 
(see below) and/or the planned repeated gathering of sheep for treatment, balanced against the 
risks of increasing spread through gathering. 
2. Vaccination
Several studies have examined the effectiveness of a footrot vaccine in sheep. On one farm with 
mixed infections of footrot and CODD, fattening lambs were randomly allocated to either receive 
just parenteral antibiotics if they had a foot lesion, or to receive a footrot vaccine and parenteral 
antibiotics if they had a foot lesion (Duncan et al., 2012). In this study, the new infection rate was 
significantly reduced in the vaccinated group compared to the just antibiotics group, with an overall 
vaccine efficacy estimated at 62%. Interestingly, this vaccine also had a small positive effect against 
CODD, possibly due to the association between footrot and CODD. This non-antibiotic tool can aid 
control particularly if given in advance of high-risk periods e.g. housing. 
3. Avoid
The idea of avoidance is to consider on a farm where the high traffic areas might be and thus where 
there is probable mixing between infected and uninfected sheep. For example the use of feeders 
can facilitate the spread of infection as all the sheep need to go to feed and therefore, the spread 
between an infected individual and uninfected sheep is more likely. The use of lime in areas of 
unavoidable high traffic can help reduce the build up of infection, although is unlikely to eliminate 
it all together. It is worth considering the siting and establishment of sheep handling facilities as 
these are areas where sheep are likely to be concentrated for periods of time increasing the risk of 
transmission, and siting them such that they drain well and are easy to clean can help reduce the 
risk of infection building up. 
4. Culling repeat offenders
Repeat offenders are those sheep that get footrot, are treated until better, and then get a new 
infection. Culling out sheep that develop repeat infections within a year has been recommended 
as part of the plan, however, there is no specific experimental evidence to demonstrate the impact 
of this specific intervention on overall flock incidence rates. It has however been shown to be 
associated with lower levels of lameness in a farm level intervention study (Witt and Green, 2018). 
The logic of this point is that those sheep that repeatedly get disease are potentially those that are 
genetically more susceptible. In a study by Winter et al., (2015) neither a greater or lower prevalence 
of lameness was associated with culling of repeatedly lame sheep, though flocks that avoided 
breeding from ewes that were repeatedly lame did have a lower lameness prevalence. 
5. Quarantining. 
In two observational studies the quarantining of sheep on arrival was associated with a 
lower prevalence of lameness or footrot (Winter et al., 2015; Wassink et al., 2003). Current 
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recommendations suggest quarantining sheep for 3 weeks or longer is best. A quarantine period 
of one month may be suitable for many other flock health reasons allowing enough time for farm 
vaccination policies to be implemented, quarantine drenching to occur etc, and it is also a message 
that is easily communicated. In addition, the isolation of lame sheep at treatment in a ‘lame’ field 
for example can help reduce spread and can also help with monitoring the response to treatment 
(Witt and Green, 2018). 
Contagious ovine digital dermatitis (CODD)
Clinically, CODD and interdigital dermatitis/footrot appear different (Figure 2) although there 
has been confusion amongst veterinarians and farmers. The aetiopathogenesis of CODD is still 
debated, but since the early identification of treponemes in affected feet, attention has focused on 
these bacteria. A more recent investigation found very strong associations between treponemes 
already associated with bovine digital dermatitis (BDD) and CODD lesions (Sullivan et al., 2015). In 
that study 58 lesions typical of CODD were identified, and in all of these one or more of these BDD 
associated treponemes were found. Furthermore, in healthy foot tissues from sheep without CODD, 
none were found. These feet were also tested for the presence of D. nodosus and F. necrophorum, 
which were also found in many of the CODD lesions. This is very strong microbiological evidence in 
favour of the hypothesis that BDD associated treponemes are also implicated in CODD. In addition, 
immunohistochemical staining with anti-Treponema spp. antibody of affected tissues also shows a 
strong association with the pathological process (Angell et al., 2015) . 
Currently, about 50% of sheep farmers report having CODD in their flocks and there are similar 
seasonal fluctuations as occur with footrot. In several studies, with different methodologies, strong 
associations have been found between footrot and CODD, in that sheep with footrot were more 
likely to have CODD concurrently and sheep vaccinated against footrot were less likely to develop 
CODD. 
Fig. 2: An early CODD lesion (L); a later more advanced CODD lesion (R). 
Treatment and control
There are few robust randomized controlled trials investigating the treatment of sheep with CODD. 
In the study by Duncan etal., (2011),) groups of fattening lambs with CODD on one farm were split 
into two groups. In the first, lambs were made to stand for 15 minutes in a footbath containing a 
1% chlortetracycline solution for three consecutive days. In the second group, lambs went through 
the same footbathing regime, but were also treated with a single long acting amoxicillin injection. 
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The antibiotic footbath led to a 53% recovery rate, but this increased to 78% with the addition of 
the long acting amoxicillin. In another study recovery just using long acting amoxicillin was 71% 
(Duncan et al., 2012. 
Over the last few years there has been lots of interest in using a whole-flock treatment approach 
to controlling or eliminating lameness, in particular CODD. One of the approaches that had been 
used was to inject all sheep on a farm at the same time with tilmicosin. Until recently, this approach 
had never been studied properly and in the light of the current global crisis around antimicrobials, 
and in particular the need to be responsible with their use, there were concerns over whether such 
a whole-flock approach was justifiable. To investigate this, initially an in vitro study to investigate 
which antimicrobials – including tilmicosin - could be potentially successful at killing the treponemes 
associated with the disease was carried out (Angell et al., 2015). This showed that treponemes were 
sensitive to many antimicrobials but that lower minimum inhibitory concentrations (MICs) could 
be achieved with penicillins and macrolides. A pilot study was then conducted whereby sheep with 
clinical CODD were given 2 injections of tilmicosin 14 days apart, which resulted in the clinical 
resolution of all 58 cases in the study. 
Following on from this a cluster randomised trial was carried out to test whether clinical CODD 
could be successfully eliminated from flocks (Angell et al., 2016). Thirty flocks were recruited to 
the study and then randomised to either continue with their treatment-as-usual (control flocks), 
or to receive a whole flock and increased biosecurity intervention. All the sheep in each flock, in 
both groups, were examined twice, once at the beginning of the study and once at the end (one year 
later) to determine the presence of foot lesions. Sheep in the control flocks were then treated as per 
the farmers’ normal routine. All the flocks in both groups were then monitored for 1 year. Clinical 
elimination was said to occur if there were no signs of clinical disease at the final visit. At analysis 
there were 11 control flocks and 13 intervention flocks. 
For the intervention flocks, all sheep were given a single dose of tilmicosin. Any sheep with clinically 
active CODD was isolated in a separate group and a second dose of tilmicosin was administered 14 
days later. Farmers were then instructed to continue the isolation of these individuals for a further 
14 days. Throughout the year farmers were instructed to isolate any sheep moved on to the farm. 
Those sheep were then inspected and treated with a single dose of tilmicosin at this point and then 
isolated for 14 days. 
On the control farms, 1/11 farms successfully eliminated CODD without the whole-flock treatment. 
On the intervention farms, CODD was successfully eliminated from 6/13 flocks. A comparison of 
these two proportions reveals no statistically significant difference between them. Footrot was not 
completely eliminated from any flock. Therefore, the clinical elimination of CODD from affected 
farms is possible for 1 year, with or without the whole-flock treatment. However, due to the ethical 
concerns surrounding the use of macrolide antibiotics in this way, the high failure rate and associated 
costs, this approach is not recommended for the clinical elimination of CODD. In light of this the Sheep 
Veterinary Society have also included in their guidelines on the responsible use of antimicrobials in 
sheep that this practice should not be used (SVS, 2017). 
Conclusion
Many of the principles for footrot control e.g the Five Point Plan will also apply for CODD. In addition, 
controlling footrot should also help reduce one of the biggest risk factors for CODD. Diagnosis has 
been an issue for many farmers and veterinarians and mis-diagnosis can lead to treatment failure. 
Farmers also need to adopt good biosecurity principles when purchasing or moving sheep in order 
to reduce the risk of spreading disease and for clinical cases adopt a treatment which is likely to be 
efficacious. 
Author email: joseph@wernvets.co.uk
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Animal Health Ireland, 4-5 The Archways, Carrick-on-Shannon, Co. Leitrim N41 WN27
Change is necessary
The importance of addressing the challenge of antimicrobial resistance (AMR) is now well-recognised, 
as are the benefits of doing so through a “One Health” approach which considers not only the 
agricultural sector but also its inter-relationships with the environment and human health. From a 
human perspective, the prediction that the human death toll due to AMR will match or exceed that 
due to cancer by 2050 is sufficient reason to address the issue, preserving these medicines for future 
generations and discharging our societal responsibilities. In addition, there are compelling reasons 
to address it from a primary production perspective. 
Given our reliance on exports, and the progress being made in some of our competitor countries, 
it is vital that Ireland is able to both demonstrate and substantiate that progress is being made. 
This is particularly so in the intensive sectors of pigs and poultry, which account for the majority 
of the 100 tonnes of antibiotics that are used in Ireland each year. The indication that some 66% of 
antimicrobials (AM) used in Ireland are given by oral medication, in feed or water, is a further cause 
for concern in relation to the increased risk of development of AMR and environmental spread 
associated with this treatment route. 
In addition, of course, the emergence of AMR at the level of the individual farm or flock is of direct 
relevance to primary producers, as sick animals become more difficult or impossible to treat and 
the risk of human infection with bacteria that are difficult to treat. While the primary focus of 
AMR tends to be on antibiotics (to treat bacteria), the demonstration of widespread anthelmintic 
resistance in both cattle and sheep (failure to respond to worm doses) also requires urgent attention. 
Reflecting all of these concerns, Regulation (EU) 2019/6, which comes into force in January 
2022, will makes elements of our efforts to address AMR mandatory, rather than voluntary, with 
prohibitions on the routine use of AM, their use to compensate for poor management and to prevent 
(rather than treat) disease and their use for group treatment. These changes will be accompanied by 
restrictions on use of certain antibiotics that are of particular importance in the human health field 
(highest-priority critically important antibiotics [HP-CIA]) and on veterinary prescriptions for AM.
Change is possible
A significant amount of work has already been undertaken within the framework of the Irish National 
Action Plan on Antimicrobial Resistance 2017-2020 (iNAP), a One Health initiative within which 
agriculture-related measures are coordinated by an Animal Health Implementation Committee. 
Key outputs from this collaborative approach already include the publication of Ireland’s First One 
Take home messages
•	 Change is required in relation to antimicrobial usage
•	 Change is possible- through measures to deliver improved animal health
•	 Change must be measured
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Health Report on Antimicrobial Use and Antimicrobial Resistance (2016); a DAFM policy on HP-
CIAs, a Code of Good Practice Regarding Responsible Prescribing and Use of Antibiotics in Farm 
Animals and guidance for prescribing veterinary practitioners on the Ethical Use of Antibiotics. In 
this context, it is important to note that the recommendations are guided by the principle of “as 
little as possible, as much as necessary”, recognizing that antibiotics remain a necessary part of 
farm animal medicine. It is important that this message is clearly communicated to consumers and 
decision makers alike i.e production systems that are antibiotic responsible, rather than antibiotic 
free.
Ultimately, a reduction in AMU on farm is largely delivered by improvements in animal health. 
In this context, the principles laid down in DAFM’s National Farmed Animal Health Strategy of 
working in partnership and that “prevention is better than cure” are noteworthy. Drawing on 
activities coordinated by Animal Health Ireland, examples will be given in the presentation on the 
opportunities to improve animal health (and, implicitly or explicitly, AMU), through vaccination, 
addressing biosecurity, disease eradication, attention to husbandry and management, and genetic 
improvement. 
In some cases, implementing change will require the setting aside of approaches that have previously 
been considered to represent, and have been communicated as, best practice. Examples include the 
routine use of blanket dry cow therapy (DCT) in dairy herds, with a move toward selective DCT, or 
a move away from the concept of “dose and move” in the management of gut worms in cattle and 
sheep.
The role of the private veterinary practitioner is central in terms of leading change in on-farm 
practices, ideally within the wider concept of veterinary herd health management planning and of 
being responsible for ensuring good antimicrobial stewardship (AMS) and demonstrating a best 
practice approach to prescribing.
The adoption of a One Health approach provides an opportunity to and interact with, learn from, 
the human and environmental sectors. In addition, it is important to share learnings between the 
different sectors of agricultural production in Ireland and to learn from approaches taken in other 
European countries.
Change must be demonstrated
Monitoring of AM use is a vital component of the overall effort to reduce usage, consistent with 
the adage that “if you can’t measure it, you can’t improve it”. Furthermore, from a marketing 
perspective, “if you can’t measure it you can’t prove it”. While the latest ESVAC report on usage 
ranks Ireland reasonably favourably amongst 31 European countries in terms of overall usage, the 
data are relatively uninformative without detailed information on each sector and, ultimately, each 
production stage and farm. Many of our competitor countries already have systems of varying 
complexity and scope in place to generate this information, and the recent launch by DAFM of a 
database to capture AM usage in the pig sector is a significant step forward, laying the basis for 
assessment of trends overtime and the use of herd-level benchmarking to foster change.
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Meet the speakers
Martin Blake 
Martin Blake is Ireland’s Chief Veterinary Office at the Department of Agriculture Food and the 
Marine (DAFM) where he has responsibility for policy development relating to animal health, 
animal welfare, food safety and veterinary public health matters, as well as the operational 
programmes and controls associated with these functions in DAFM’s ‘One Health, One Welfare’ 
business area. He serves as delegate of Ireland to the OIE (World Animal Health Organisation), 
is a member of the OIE European Region Steering Group on animal welfare and currently is chair 
of the Food and Agricultural Organisation of the United Nations’ European Commission for the 
Control of Foot and Mouth Disease (EuFMD). He co-chairs, with the Chief Medical Officer of the 
Department of Health, the National Inter-Department AMR Consultative Committee and is a 
past member of the Veterinary Council of Ireland. He is a graduate of University College Dublin 
in Veterinary Medicine and Business Administration.
Prof. Martin Cormican,
Prof. Cormican, MB, BCh, BAO and MD, member of the Royal College of Physicians (UK) and 
a Fellow of the Royal College of Pathologists.  He is lead of the HSE Antimicrobial Resistance 
and Infection Control Team, Chair of the Discipline of Bacteriology at NUI, Galway, and 
Consultant Microbiologist at Galway University Hospitals, Director of the National Salmonella 
Shigella and Listeria Reference Laboratory, Director of the National Carbapenemase Producing 
Enterobacteriaceae (CPE) Reference Laboratory, Director of the Centre for Health from 
Environment at the Ryan Institute NUI Galway.  He is also a member of the Scientific Steering 
Board of the One Health European Joint Programme, a member of the National Public Health 
Emergency Response Team, and a member of the National CPE Expert Group.  He was a member 
of the Food Safety Authority of Ireland (FSAI) Scientific Committee and the FSAI Biological 
Safety subcommittee for 15 years. He has over 25 years’ experience of research on antimicrobial 
resistance. He has over 200 publications.  He will inform identification of key stakeholders, 
facilitate contact with same and advise on development of key intervention points.
Caroline Garvan 
Caroline is the Superintending Veterinary Inspector in the AMR Division of the Department of 
Agriculture, Food and Marine. She qualified as a veterinary surgeon in 1993 and spent 12 years 
in mixed practice in both the UK and Ireland before joining the Department of Agriculture, Food 
and Marine in 2007. Since joining the Department she has worked in the medicines division, 
and then moved into the AMR unit in 2017. Caroline completed a post-graduate certificate 
in Food Safety in 2005 and an MPhil in Food Safety and Environmental health in 2007. She 
recently completed a Diploma in Leadership which helps in her role as the programme manager 
of Ireland’s national action plan on AMR.
Dr Dearbháile Morris
Dearbháile Morris is a Lecturer and Head of the Discipline of Bacteriology at the School of 
Medicine, National University of Ireland Galway. Dearbháile established the Antimicrobial 
Resistance and Microbial Ecology Group in 2010 and is Co-Director of the Ryan Institute Centre 
for One Health. Dearbháile’s research group works closely with national and international 
research groups and other agencies focusing on antimicrobial resistance, food and water borne 
pathogens, emerging contaminants, and the wider societal impact of infection and One Health. 
Dearbháile is leading the four year EPA/HSE-funded “AREST: Antimicrobial Resistance and the 
Environment – Sources, persistence, Transmission and risk management” project and the EPA-
funded “PIER: Public Health Impact of Exposure to Antibiotic Resistance in Recreational Waters” 
project. 
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Martin Kavanagh 
Martin Kavanagh ,MVB Cert DHH, qualified as a veterinary surgeon from University College 
Dublin in 1993 and spent 14 years in mixed veterinary practice in south Tipperary. In 2007, he 
joined Richard Keenan and Co. Ltd as Veterinary Director which gave him the opportunity to travel 
throughout Ireland, UK, continental Europe, and Australasia, developing practical solutions for 
management of cow health.  Since 2009, Martin directs ‘Cow Solutions’, an independent company 
providing cow and calf management system solutions, and troubleshooting production problems. 
He is a certified ‘Cow Signals®’ Master Trainer and provides training in farm system management 
and farmer communications for a variety of groups in Agri-industry. He works with large herds 
in Ireland and Scandinavia developing management systems to reduce antibiotic usage. Recently, 
Martin has been engaged with development of agritechnology with a number of companies and 
is involved in looking at new ways to improve animal welfare outcomes in intensive production 
units. His goal is to communicate practical help and advice to improve the life of the animals, and 
the farmer, while respecting the needs of the consumer.
Dr Aine Regan 
Áine Regan works as a Research Officer (Social Science) with Teagasc, the Agriculture and Food 
Development Authority of Ireland. In her research work, she uses behaviour change models and 
science and risk governance frameworks to help develop evidence-based and societally acceptable 
strategies for behaviour change in food and agriculture. She employs quantitative and qualitative 
research methodologies to understand the attitudes, values, motivations and behaviours of 
actors in the agri-food sector (e.g. consumers, farmers, policy-makers and scientists) so that they 
are accounted for in the development of policies, products, and practices. Áine has a degree in 
Psychology and a Masters in Health Psychology (National University of Ireland, Galway) and a 
PhD specialising in the perception and communication of food-related risks (University College 
Dublin). Áine previously worked in University College Dublin and the University of Ottawa 
before joining Teagasc in 2015.
Finola Mc Coy 
Finola graduated from University College Dublin in 1997 with a degree in veterinary medicine. 
She spent the following 11 years working in various mixed practices in Ireland, UK and New 
Zealand, and during this time developed a keen interest in the dairy industry. Working with 
large dairy herds in New Zealand provided an invaluable insight into some of the challenges 
associated with herd expansion and disease control. While working in practice she undertook a 
Masters in Science in Livestock Health and Production through the University of London, which 
was completed in 2006.
She joined the Teagasc research team in Moorepark in 2008, as the mastitis research officer. 
While working for Teagasc she commenced working as Programme Manager for CellCheck, which 
is the national mastitis control programme. She joined the AHI in May 2013 to continue working 
in this role. As programme manager, she is responsible for facilitating the Irish dairy industry 
to work collaboratively to identify and develop sustainable solutions to continually improve 
the udder health of the national dairy herd. She was awarded a Nuffield scholarship in 2014, 
to explore the topic of building strong professional teams and networks among rural service 
providers.
David Tisdall 
David Tisdall,  BVSc (Hons) GradDip CertCHP FHEA MRCVS,  is Head of Department of 
Clinical Veterinary Sciences and Senior Teaching Fellow in Production Animal Medicine at the 
University of Surrey School of Veterinary Medicine. He graduated from University Bristol, School 
of Veterinary Sciences in 2006 and has more than 10-years’ experience of clinical farm animal 
practice. As clinical lead of Langford Farm Animal Practice he led transformational change 
towards more responsible antimicrobial use on farms, achieving more than a 90% reduction in the 
use of critically important antimicrobials, whilst continuing to improve herd health. Alongside 
veterinary education, he has particular clinical interests in the management and prevention 
of production diseases in dairy cattle and motivating change towards more responsible and 
sustainable use of medicines in farm animals. 
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Dr Emer Kennedy
Emer Kennedy is a Senior Researcher with Teagasc, based in Moorepark, Fermoy, Co. Cork and 
has responsibility for the Teagasc dairy calf and heifer rearing programme.  She is originally from 
a dairy and beef farm in Co. Kilkenny.  Emer graduated from UCD after completing an Agricultural 
Science degree.  Following this she went to Teagasc Moorepark to undertake her PhD.  In 2008 
she began work on rearing replacement heifers for the dairy herd and now has a large programme 
of work in progress which focuses on rearing the new born calf right up to the pre-calving stage. 
Over the past number of years this work has focused on colostrum management and strategies 
to promote calf health and welfare.
Catherine McAloon 
Catherine qualified from UCD in 2011 and worked in mixed practice in Ireland for 3 years before 
returning to UCD to undertake a residency programme in the Herd Health Department of the 
School of Veterinary Medicine.  In 2017, Catherine successfully passed her European Board 
examinations and is a European Specialist in Bovine Health Management.  She is also a RCVS 
recognised specialist in cattle health and production.  Catherine works as an Assistant Professor 
in the Herd Health and Animal Husbandry section of UCD. She is currently chair of the Animal 
Health Ireland technical working group on calfcare.
Dr Carla Gomes 
Carla Gomes graduated as a veterinary practitioner from the University of Porto, Portugal 
in 2002. She worked for several years in small animal practice while studying for her MSc in 
Veterinary Public Health in Lisbon Technical University, focusing on Johne’s disease in dairy 
cattle. She lectured in epidemiology and public health for some years in the University of Porto 
and completed a PhD in Salmonella in pigs, specialising on risk characterisation and modelling 
of disease transmission within a herd. In 2012 Carla moved to Scotland and worked for the 
Epidemiology Research Unit (ERU) SRUC -  for seven years. There she was involved in several 
projects related to the British pig sector and other livestock species, with the aim to provide 
relevant epidemiological science that meets the needs of policy-makers and industry.  Several of 
the projects with the Scottish and English pig industries involved the application of quantitative 
methods to allow data from different sources (e.g. abattoir data) to be integrated and applied 
effectively. Carla joined Animal Health Ireland (AHI) in September 2019 as the programme 
manager for the Pig HealthCheck Programme. The Pig HealthCheck is an AHI-led programme co-
funded by pig producers and DAFM, with the aim of improving the profitability and sustainability 
of the Irish pig industry through improved animal health.
Rob Doyle
Rob Doyle is Senior Superintending Veterinary Inspector in DAFM’s Antimicrobial Resistance, 
Veterinary Medicines, Animal Welfare and Ruminant Trade (AMWeRT) Division.  A 1988 Dublin 
Veterinary Graduate, Rob worked in General Practice before joining Department of Agriculture, 
Food and the Marine (DAFM) in 1994,  since then he has held a wide variety of roles in DAFM 
which have included managing the veterinary internal audit unit and managing the Regional 
Veterinary Office in Drumshanbo. Rob has managed  AMWeRT division since 2018. 
Dr. Orla Keane 
Orla is a Senior Researcher at the Teagasc Animal & Bioscience Department in Grange, Co. 
Meath.  Orla has a first class honors degree in microbiology from Trinity College, Dublin.  She also 
completed her PhD in molecular microbiology at Trinity College Dublin where she also graduated 
with a post-graduate Diploma in Statistics.  She subsequently undertook post-doctoral studies 
in animal genomics and host resistance to gastrointestinal nematodes at the Molecular Biology 
Unit, AgResearch, New Zealand and in bioinformatics at the Department of Genetics in Trinity 
College Dublin.  She has been a researcher at the Teagasc Animal & Bioscience Department since 
2009 in the area of infection biology.  Her particular interests are in intramammary infection 
and gastrointestinal nematode infection and the role of pathogen and host diversity in mediating 
the response to and outcome of infection.  She has a particular interest in antimicrobial and 
anthelmintic resistance among animal pathogens.  
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Dr Joe Angell
Joe graduated in Veterinary Medicine  from the University of Liverpool in 2008 and since then has 
divided his time between clinical practice and research.  He has an MSc in Epidemiology from the 
London School of Hygiene and Tropical Medicine and a PhD on the Epidemiology of contagious 
ovine digital dermatitis (CODD) from the University of Liverpool.  He is now Associate Partner 
at Wern Veterinary Surgeons in north Wales and has recently established there a Department of 
Research and Innovation working on practical answers to questions encountered in practice.  He 
is also an Honorary Fellow of the University of Liverpool. 
Dr David Graham 
Dr David Graham is the current CEO of Animal Health Ireland. He qualified from UCD as a 
Veterinary Surgeon in 1988, and after working as a house surgeon at the Veterinary School in 
Dublin he moved back to Northern Ireland where he spent several years in mixed large animal 
practice. In 1992 David joined the Stormont laboratories of the Veterinary Sciences Division of 
the Science Service (now the Agri-food and Biosciences Institute) where he worked in several 
branches. During his time there he gained extensive experience in the diagnosis and control of 
a wide range of viral and bacterial diseases, including bovine viral diarrhoea (BVDV), infectious 
bovine rhinotracheitis (IBR), Johne’s disease and leptospirosis. He received his PhD in 1998 on 
improved methods for diagnosing bovine respiratory disease from Queen’s University Belfast. 
In 2007 he established, and subsequently led, a cattle health scheme offering monitoring, 
eradication and accreditation programmes for BVD, IBR, Johnes and leptospirosis. David joined 
AHI in October 2010 and held the position of Deputy CEO prior to his appointment as CEO 
in September 2017. In 2016 he was awarded a Fellowship of the Royal College of Veterinary 
Surgeons in recognition of his meritorious contribution to knowledge. 
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Notes
Contact Us:
Teagasc, Head Office, Oak Park, Carlow.
Tel: 059-9170200 Email: info@teagasc.ie Web: www.teagasc.ie
